Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Sep 26.
Published in final edited form as: Crit Rev Immunol. 2018;38(2):79–103. doi: 10.1615/CritRevImmunol.2018025653

Tissue-specific Control of Tissue Resident Memory T Cells

Yong Liu 1,2, Chaoyu Ma 1, Nu Zhang 1,3,*
PMCID: PMC6156774  NIHMSID: NIHMS989125  PMID: 29953389

Abstract

Tissue-resident memory T (TRM) cells have emerged to be a major component of T cell biology. Recent investigations have greatly advanced our understanding of TRMs. Common features have been discovered to distinguish memory T cells residing in various mucosal and non-mucosal tissues from their circulating counterparts. Given that most organs and tissues contain unique microenvironment, local signal-induced tissue-specific features are tightly associated with the differentiation, homeostasis and protective functions of TRMs. We will discuss the recent advances in TRM field with a special emphasis on the interaction between local signals and TRM cells in the context of individual tissue environment.

Keywords: CD4, CD8, Infection, IL-15, Memory, TGF-β

Introduction

T lymphocytes or T cells are the central component of adaptive immunity. To prepare for the vast majority of potential antigenic encounter, T cells harbor a large repertoire of different T Cell Receptors (TCRs) with diverse reactivity. For each given TCR specificity, only a small number of T cells are present in human and un-manipulated mice due to the limit of total T cells that an individual can host.1 Therefore, to effectively patrol the most parts of a body for potential pathogen invasion or other antigenic challenge, circulation and migration is an essential feature tightly associated with T cell function.

Under steady state, naïve T cells circulate through secondary lymphoid organs, blood and lymphatic vessels.2 Upon antigen stimulation, naïve T cells differentiate into effector T cells with newly equipped effector functions that actively eliminate antigenic sources.3 At later stages of an immune response, most effector T cells die via apoptosis and a small number of survived cells further differentiate into memory T cells, which carry the unique feature of adaptive immunity—immunological memory.4 Although long-lasting debates have been focused on the identity of memory precursors and the differentiation path of memory T cells,5 recent works have provided solid epigenetic evidence that virus-specific memory T cells transit through an effector stage, not directly derive from naïve cells in both mouse and human.6,7

Early studies in human peripheral blood have identified two distinct memory T cell populations based on their unique migratory patterns, namely central memory T cells (TCM) and effector memory T cells (TEM).8 TCMs carry lymph node homing receptors CCR7 and CD62L, and share a similar circulation path as naïve T cells. In contrast, TEMs lack CCR7 and CD62L, and prefer non-lymphoid peripheral tissues during circulation. In addition to divergent migration patterns, different proliferative potential and effector functions have been attributed to TCM and TEM. Similar circulating memory T cell subsets have been confirmed in mouse and other animal models.9

Partition of memory T cells into TCM and TEM provides a convenient model to investigate the migration and function of memory T cells. However, in contrast to the generally accepted notion that TEM cells patrol non-lymphoid tissues under steady state, recent studies have discovered that during local inflammation, TCMs, but not TEMs or long-lived effector T cells, migrate into inflamed tissues due to their superior capacity to induce O-glycosylation and generate P/E-selectin ligands, which facilitate the trans-endothelial extravasation of T cells.10,11 Comparing with TEM, TCM cells generally express higher level of chemokine receptor CXCR3, which also enhances the migration of TCM into inflamed peripheral tissues.12 Thus, the migration pattern of memory T cells is dynamically controlled by inflammatory signals independent of antigenic stimulation.

A population of non-circulating tissue-resident memory T cells (TRM) has been identified in almost all non-lymphoid tissues in both human and mouse.1319 It has been estimated that the number of TRM cells exceeds the number of T cells in all lymphoid tissues and entire blood volume combined in both adult human and immunized mice. Therefore, as a newly discovered major T cell population, TRM is a focus of extensive and active investigations.

Based on the results from decades of research on mucosal T cells, it is quickly realized that mucosal lymphocyte surface marker integrin αEβ7 (CD103) marks mucosa-associated TRM cells.20,21 Although with various specificity and accuracy, CD103, together with CD69 has been widely accepted as the common markers to identify TRM cells in mucosal and some non-mucosal tissues in both mouse and human. Transforming growth factor-β (TGF-β) is a pleiotropic cytokines that control various aspects of T cell biology including thymocyte development, naïve T cell homeostasis and effector/memory T cell differentiation.22,23 For more than two decades, it has been known that TGF-β enhances the expression of CD103 on activated T cells during in vitro culture.24 Later, it has been validated in different in vivo models that TGF-β signaling is tightly linked with TRM biology, which will be discussed in details in the following sections.

In current review, we will focus on the recent advances in TRM biology and will specifically address the following topics: I) Tissue-specific features of TRM cells; II) Transcriptional control of TRM cells and III) CD4+ TRM cells. As a rapidly expanding field, exciting overlap between TRM cells and tumor infiltrating T cells has been observed. Due to the scope of current review, infection-induced TRM cells will be the major topic with a special emphasis on the relationship between TGF-β signaling and TRM biology. As CD4+ TRM cells will be discussed in the last section, CD8+ TRM cells will be the main focus in the first two sections.

I. Tissue specific features of TRM cells

TRM cells are broadly distributed in both mucosal and non-mucosal tissues outside lymphoid compartment. In addition, a small number of CD8+ TRM cells reside in secondary lymphoid organs isolated from infected mice and Peyer’s patches from naïve mice.25,26 Interestingly, a substantially increased population of memory T cells bearing TRM markers is present in the secondary lymphoid organs isolated from adult human27,28 presumably due to prolonged history of antigen exposure.29 A recent report has demonstrated a direct link between non-lymphoid tissue resident CD8+ T cells and TRM cells in the draining LNs.30 Secondary lymphoid organ TRMs are largely differentiated from non-lymphoid tissue TRMs during re-infection. However, the biological importance of secondary lymphoid organ-resident CD8+ TRM is not entirely clear. In this section, we will focus our discussion on the recent discoveries of TRM cells in a collection of non-lymphoid organs.

A. Skin

Skin harbors a large number of antigen-specific CD8+ TRM cells following various infections in both mouse and human.31,32 As one of the pioneer focuses of TRM research, skin TRM population is relatively well characterized. During the early phase of skin infection, effector CD8+ T cells with a Killer Cell Lectin Like Recrptor G1 (KLRG1-) phenotype (i.e., the common precursors for memory T cells) migrate to the skin via a P/E-selectin ligand- and CXCR6-dependent manner.3335 Skin TRMs isolated from both mouse and human share common TCR sequences with circulating memory T cells in the lymph nodes from the same individual, suggesting that common precursor effector T cells give rise to both skin-resident and circulating memory T cells.36

Using skin Vaccinia virus (VACV) infection model, it has been demonstrated that DNGR-1+ dendritic cell (DC)-mediated cross-Priming is specifically required for the formation of skin TRM, but not for that of circulating memory T cells.37 CD8α+ DCs in mouse lymphoid organs and CD103+ DCs in non-lymphoid organs express chemokine receptor Xcr1 and C-type lectin DNGR-1 (encoded by Clec9a). This subset of DCs develop in a transcription factor Batf3-dependent manner and exhibit superior capacity to cross-Present exogenous antigen to CD8+ T cells.38,39 Interestingly, it is in the draining lymph node (LN) during the very early phase of naïve CD8+ T cell priming that DNGR1+ DCs deliver critical signals to instruct CD8+ T cells to differentiate into skin TRM at later stages.37 Cross-Priming DCs extend the retention of activated CD8+ T cells in draining LNs via repressing transcription factor Kruppel Like Factor 2 (K1f2) and its target Sphingosine-1-Phosphate Receptor 1 (S1pr1). Defects in cross-Priming DCs result in early egress of CD8+ effector T cells from the draining LNs and enhanced accumulation of KLRG1+ effector CD8+ T cells in the skin at early stages following infection. Further, DNGR-1+ DCs provide IL-12, IL-15 and CD24 signals, all of which are required for optimal formation of skin TRM cells.37 A separated line of research has established Xcr1+ cross-Priming DCs as an essential player to convey CD4-help signals during CD8+ T cell priming in the LNs.40,41 Even though CD4-help is not required for the initial recruitment of CD8+ effector T cell to the skin,33 the role of CD4-help in the formation and long-term maintenance of skin TRM population remains to be determined. Indeed, CD4+ T cell depletion leads to enhanced CD8+ T cell recruitment to the skin,33 phenocopying the accelerated lymph node egress and increased skin CD8+ T cell accumulation in cross-Priming DC deficient animals at the early phases of an infection.37 Together, it is likely that through cross-Priming DCs, early CD4-help is required for the formation of skin TRM cells.42 However, the molecular programs linking CD4 helped effector CD8+ T cells in the LNs with later formed skin TRMs remain to be elucidated, although a recent work started to dissect the connections.43

After arrival at the skin, CD8+ T cells up-regulate CD69 and CD103 in a progressive order.34 CD69 promotes the early retention of CD8+ T cells in the skin before the expression of Klf2 and S1pr1 are efficiently suppressed.44 Mechanistically, CD69 inhibits the function of S1pr1 and blocks the egress of T cells.45 Even though the down-regulation of Klf2 and S1pr1 is a common signature of TRM,46 the rapid induction of CD69 helps to retain TRM precursors when there is residual activity of S1pr1 at early stages of TRM differentiation. In the absence of CD69, skin TRM population is greatly reduced. However, CD69 deficient T cells can differentiate into CD103+ TRMs in the skin, similar as the situation in lung TRM cells.47 These results demonstrate that CD69 per se is not required for the subsequent differentiation of TRM cells. The induction of CD69 in skin TRM cells is independent of TGF-β and type I interferon (IFN). Local antigen is not required for skin TRM formation.48 However, local antigen greatly promotes CD69 induction and skin TRM differentiation.4951 Using VACV skin infection model, it has been demonstrated that the early recruitment of activated CD8+ T cells to the skin is cognate antigen-independent. After arrival, skin T cells compete for antigen-Presenting cells for cognate antigen recognition, which leads to the induction of CD69. Notably, local TCR signal only provides differentiation, but not proliferation signals to TRM precursors.50,51

TGF-β is required for the induction of CD103 and long-term maintenance of skin TRM cells.34 The expression of CD103 reduces the mobility of skin TRM cells as demonstrated by multi-photon microscopy.35 Integrin αvβ6 and αvβ8 expressed by keratinocytes cooperate to activate latent TGF-β and are essential for the maintenance of skin TRM population.52 Interestingly, the activity of αvβ6 and αvβ8 is continuous required even after the establishment of skin TRM population. This observation suggests that the unique TRM transcription program is not permanently fixed. Instead, constant environmental cues (e.g., TGF-β) are essential to maintain the identity of skin TRM cells at least under the circumstance of systemic viral infection. Most CD8+ skin TRM cells reside in the epidermis layer. Hair follicle derived IL-7 and IL-15 and a special metabolic program involving exogenous lipid uptake are required for the long-term survival of skin TRM cells.53,54 Further, as a skin homing chemokine receptor, CCR10 is required for the long-term homeostasis of both circulating and skin-resident memory CD8+ T cells during skin infection.35

A small number of CD8+ T cells can seed distal non-infected regions of the skin and provide critical local protection, suggesting that a low number of skin TRMs are sufficient to provide effective protection.33,49 Re-encounter of cognate antigen induces rapid activation of skin TRM cells. Activated TRMs stimulate both innate and adaptive immune components of the skin and recruit circulating memory T cells in an IFN-γ-dependent manner.55 Skin TRMs provide sufficient protection in adult human as demonstrated by the lack of infections in alemtuzumab-treated cutaneous T cell lymphoma patients whose circulating T cells are depleted while skin TRM cells are spared.56 During the recall response, skin TRM cells undergo in situ expansion and contraction, and do not rejoin circulating effector/memory T cell pool. Thus, skin TRM population is a relatively stable local immune component during the subsequent challenges.57

Most previously mentioned skin TRM cells are generated in response to a specific pathogen introduced by intradermal injection or scarification, which causes both local infection and skin damage. Without causing skin injury, topical application of certain strains of skin commensal bacteria leads to a typical antigen-specific CD8+ T cell response including expansion, contraction and long-term maintenance of a memory T cell population in the skin carrying a common TRM phenotype (i.e., CD69+CD103+).58 In addition to IFN-γ producing cells, this commensal bacteria-induced skin TRM population contains a significant subset of IL-17 producing cells. Cross-priming DCs are required for the formation of these IL-17+ CD8+ TRM cells. In addition to the divergent effector cytokines, regular pathogen-induced TRMs are different from commensal-specific TRMs in three major aspects: 1) Pathogen infection-induced skin TRM cells are largely restricted to the injured site while commensal-specific TRMs are scattered; 2) Pathogen infection-induced TRMs directly respond to infected epidermal cells to produce IFN-γ while IL-17 production from commensal-specific TRM cells requires CD11b+ local DCs;5860 and 3) the unique population of IL-17 producing CD8+ skin TRM cells differentiate from non-classical MHC-Ib-restricted CD8+ T cells and promote tissue repair.59

As a common TRM signature, skin TRM cells exhibit a T-betloEomesneg phenotype.60 In T-bet deficient cells and therefore complete lack of T-box transcription factors, skin TRM cells up-regulate transcription factor RORγt and become IL-17 producing cells.60 Similar IL-17-Producing CD8+ T cells have been observed in T-bet/Eomes double deficient T cells in lymphoid organs after systemic viral infection.61 Commensal bacteria-induced IL-17+ skin TRM cells carry minimal amount of T-bet while maintain a high level of RORγt, suggesting that upon the suppression of T-box transcription factors, RORγt-mediated type 17 effector program may be an important default path of CD8+ T cell differentiation. Importantly, IL-17 producing CD8+ T cells are present in both human and non-human primates.59 In human skin, the presence or absence of CD49a expression can divide TRMs into IFN-γ or IL-17-Producing cells and associated with type 1 or type 17 effector T cell-related disease settings.62 However, the molecular and cellular control of the type 17 effector program in CD8+ T cells or TRM cells remains unclear.

Together, skin TRM cells are differentiated from common memory T cell precursors in the circulation. Local antigen is not required, but significantly promotes the induction of CD69 and differentiation of skin TRMs. Local signals including TGF-β, IL-7 and IL-15 controls the formation and homeostasis of skin TRMs. Pathogen-induced and commensal-specific TRMs exhibit distinct features.

B. Lung

Lung TRM cells exhibit both common TRM features and lung-specific properties. Most lung parenchyma and interstitium-resident CD8+ memory T cells carry either CD69+CD103+ or CD69+CD103 phenotype, similar as TRMs isolated from most other mucosal sites. Lung CD8+ TRM cells are essential for the local protection against influenza viral infection in mouse.6366 Further, it has been recently confirmed that influenza-specific TRM cells isolated from human lungs mount a robust proliferative response with superior effector functions.67

The differentiation of CD103+ lung TRM cells is TGF-β-dependent64,68 and requires CD4-help and cross-Priming signals from DNGR-1+ DCs during the initial priming phase.37,42 4–1BB signal to T cells is critical for the formation of lung TRM cells in a competitive setting.69 In addition, Notch signaling and Notch inducing transcription factor EGR2 are up-regulated in CD103+ lung TRM cells and essential for the formation and maintenance of lung TRM cells.70,71 The survival of CD103+, but not CD103 lung TRM requires IL-15 signaling.60 Interestingly, Notch may promote the maintenance of lung TRM cells via an IL-15-independent and metabolism-related mechanism.70

In contrast to antigen-independent and local inflammation-driven TRM differentiation in the vagina and salivary gland, local cognate antigen is essential for lung TRM differentiation,47,64 consistent with the findings that T cells with different TCR specificity elicit distinct TRM forming potential during polyclonal response against influenza virus infection in mice.67,72,73 Further, TCR signal can induce the expression of anti-viral protein IFITM3 (Interferon Induced Transmembrane Protein 3) in lung TRM cells. IFITM3 protects lung TRM cells from direct viral infection-induced cell death.74

Distinct from long lasting protection provided by TRM cells residing in other mucosal sites, lung TRM cells wane over time due to enhanced apoptosis of CD103+ TRM in lung microenvironment.63,75 The maintenance of CD8+ memory compartment in the lung requires continuous recruitment of circulating memory T cells.76,77 In contrast to lung TRM differentiation during the acute phase of influenza virus infection, at the memory phase, previously infected lung is permissive to de novo TRM differentiation from circulating TEM cells in a cognate antigen-independent, but IL-33 and TNF-dependent manner.75 The waning of lung TRM cells is caused by the increase of circulating TCM and decrease of TEM, and therefore the decline of continuous TRM induction.

Not completely exclusive from the above explanation, recent publications have identified a specific niche in injured lungs that supports TRM differentiation and maintenance. These lung TRM niches are the tissue repair-associated regions and co-localize with the production of TRM promoting factors TGF-β and IL-15.47,72 Notably, the regeneration of damaged airway epithelium is also TGF-β-dependent,78 providing an example of complex functions of TGF-β signaling in both local immunity and tissue homeostasis. The gradual decline of lung TRM cells is caused by the completion of injured lung regeneration and the shrinking of lung TRM niches. These observations are also consistent with the lack of lung TRM formation in most systemic infection models that do not induce significant lung injury.

Thus, gradual changes of both circulating memory T cells and lung microenvironment may be together responsible for the decline of lung TRM cells over time. However, there is one piece of observation needed to be reconciled. Considering that TEM cells continuously migrate and differentiate into lung TRM cell after influenza viral infection,75 it seems counterintuitive that seven weeks of parabiosis does not lead to significant de novo lung TRM formation in a similar animal model.47 One possible explanation may be that parabiosis surgery itself causes unexpected inflammation and tissue damage. Systemic and local inflammatory signals introduced by surgical procedures may alter the migration of circulating memory T cells as TCM cells are sensitive to inflammation-induced O-glycosylation and migration.11 It is well documented that surgery has immediate impacts on the immune system of human patients.79 Therefore, even as the golden standard in TRM research, the results from parabiosis experiments should be carefully interpreted along with the experiments involving less invasive procedures.

CD69 promotes the early migration and retention, but not the differentiation or long-term maintenance of lung TRM cells.47 Similar as skin TRMs, early expression of CD69 inhibits the residual activity of K1f2/S1pr1 pathway. In addition, CD69 may directly facilitate effector CD8+ T cell migration into inflamed lung via interacting with its ligands myosin light chain 9, 12a and 12b.80

Using VACV immunization and infection models, it has been demonstrated that intranasal, but not systemic intra-Peritoneal infection induces the differentiation of two populations of lung CD8+ TRM cells, i.e., a major population of CXCR3lo interstitium TRM and a minor population of CXCR3hi airway TRM. CXCR3lo TRM cells provide critical protection.81 An independent investigation also confirms that CXCR3hi and CXCR3lo lung CD8+ T cells represent different differentiation stages in response to local inflammation (e.g., IL-12 and IL-15) and occupy distinct niches in the lung. Further, cooperative action from both CXCR3hi and CXCR3lo lung TRMs is required for the protection against lethal respiratory VACV challenge.12 Considering that CXCR3hi airway-resident CD8+ T cells are established protectors against respiratory infections,82,83 lung TRM cells may not represent a homogenous population of cells. Instead, different subsets or differentiation stages of TRM cells may occupy different niches and cooperate to achieve maximal protection.

In terms of effector functions for lung TRM, in addition to IFN-γ production, which is a common effector cytokine produced by TRMs isolated from various tissues, tissue-specific production of IL-22 is labeled as a unique feature for lung TRM cells upon cognate antigen re-stimulation.84

Together, during the effector phase of a respiratory infection, lung TRM cells are formed in a cognate antigen-dependent and CD69-dependent manner. During the memory phase, de novo TRM formation and maintenance may be mediated by an antigen- and CD69-independent mechanism. Local signals, such as TGF-β, IL-15, IL-33 and TNF promote lung TRM differentiation and homeostasis. Different microenvironment inside the lung supports various subsets of lung TRM cells.

In addition to lung TRM, a series of elegant investigations have established upper respiratory tract as a key site to support local TRM against respiratory viral infection.73,85,86 Virus-specific CD69+ and CD69+CD103+ CD8+ T cells carrying common TRM signature genes can be readily isolated from upper respiratory tract including nasal tissue and nasal-associated lymphoid tissues in mouse and tonsils in human. Distinct from TGF-β- and cognate antigen-dependent induction of lung TRM cells, both TGF-β and cognate antigen recognition are dispensable for upper respiratory tract TRM cells. Further, in contrast to the gradual decline of lung TRM cells over time, upper respiratory tract TRM cells persist at a steady level and are sufficient to provide protective immunity.73 Thus, upper and lower respiratory tract associated TRM cells provide us a perfect example that different local environment supports TRM differentiation and maintenance through distinct mechanisms.

C. Intestine

Intestine contains one of the largest mucosal surfaces in the body. The complete overview of intestinal T cell components is beyond the scope of current review. In this section, we will limit our discussion to CD8αβ+TCRαβ+ memory T cells residing in the intraepithelial lymphocyte (IEL) and lamina propria (LP) compartments of the intestines.

Both local and systemic infection leads to the generation of gut CD8+ TRM cells. Local infection is often more effective in inducing gut TRMs. Generally, most TRM cells carry a CD69+CD103+ surface phenotype in the IEL compartment while LP TRM cells contain both CD69+CD103+ and CD69+CD103 subsets. CD103+ TRM cells are evenly distributed. CD103 TRM cells are clustered around infected loci in the LP of both small and large intestines via a CXCR3-dependent mechanism and critical for local immunity.87 In contrast to most other mucosal and non-mucosal tissues, local antigen is not required for the differentiation of gut TRM cells. Indeed, persistent local antigen may inhibit gut TRM cell formation revealed by delayed induction of CD103.88

During the early phase of oral infection, intestinal CD8+ T cells congregate around infected cells and receive inflammatory signals (e.g., IL-12). IL-12 prevents the induction of CD103. However, in the absence of IL-12 signaling, although the initial induction of CD103 is accelerated, the long-term survival of both CD103 and CD103+ gut TRM cells is significantly impaired.89 These results provide an elegant example of the complicated impacts of local inflammation on the differentiation and maintenance of TRM cells.

During chronic viral infection, TGF-β inhibits the expression of gut-homing receptor integrin α4β7 on effector CD8+ T cells isolated from secondary lymphoid organs and therefore dampens the migration of effector CD8+ T cells to the intestine.90 Interestingly, low dose rapamycin treatment during the effector phase of an immune response inhibits the expression of gut homing receptors and greatly reduces the formation of gut TRM population.91 Considering that TGF-β inhibits the serine and threonine kinase mammalian target of rapamycin (mTOR) in NK cells,92 the possible crosstalk between TGF-β signaling and mTOR pathway in gut TRM cell biology warrants future investigation.

In the intestinal tissues, TGF-β signaling is required for the induction of CD103, but dispensable for CD69 expression.87 TGF-β is essential for the differentiation of gut TRM cells during both local and systemic infections as TGF-β unresponsive TRMs (both CD103+ and CD103) are dramatically reduced in both IEL and LP compartments of the intestines at the memory phase of an immune response.90,93 However, in contrast to the generally accepted notion that CD103 helps gut TRM cell retention by interacting with epithelial derived E-cadherin, CD103 deficient T cells only exhibit a two-fold reduction in the initial establishment, but not in the long-term maintenance of gut TRM cells in the IEL compartment.93 CD103 is not involved in the homeostasis of gut TRMs in the LP compartment.88,93 These results demonstrate that TGF-β mediates essential functions via CD103-independent mechanisms in gut TRM cells.

Through abrogating the function of latent TGF-β activating integrin αvβ6 in the gut, it has been recorded that continuous TGF-β signaling is required for the maintenance of gut TRM cells in the IEL, but not LP compartment.52 However, underlying mechanisms explaining the difference between IEL and LP compartments are not addressed. Different TGF-β dependency of TRM subsets or additional molecules mediating the activation of local TGF-β in the LP may be the possible explanations. The factors that mediate the long-term survival of gut TRM cells are not clear. In contrast to lung and skin TRM cells, IEL and LP gut TRM cells are maintained in an IL-15-independent manner.94

In addition to the common effector molecules associated with memory CD8+ T cells, gut TRM cells have been demonstrated to produce both type I and type III IFNs to activate the innate antiviral status of gut epithelium.95 However, whether these properties are gut-specific or generally associated with TRMs isolated from other tissues awaits future clarification.

Together, intestinal TRM is formed during both local and systemic infection in a cognate antigen-independent manner. CD103+ and CD103 TRM cells exhibit different location and function. TGF-β, but not IL-15 is required for the initial differentiation and long-term maintenance of gut TRM cells. The capacity to respond to (e.g., IL-12R) or being recruited to (e.g., CXCR3) local inflammatory loci controls the formation and homeostasis of gut TRM cells.

D. Female reproductive tract

Female reproductive tract (FRT) represents another well-studied mucosal tissue in TRM field. Similar to skin, CD8+ TRMs are highly enriched in the epithelial layer of FRT.32 Remarkably, different segments of FRT exhibit distinct immunological properties that impact CD8+ T cell priming and TRM formation. The unique local environment of lower FRT restricts the immediate production of type I and type III IFN following vaginal viral infection, which in turn results in defective DC maturation and delayed CD8+ T cell priming.96 Interestingly, the dampened innate immune response is restricted to lower FRT while upper FRT mounts a relatively normal response. The mechanisms underlying this striking difference between lower and upper FRT remain unknown. In addition to variable immune components, different epithelial structure and the restricted association of microbiome with lower FRT may be the potential contributing factors.97

After priming, the migration of activated CD8+ T cells to vaginal mucosa is tightly regulated by local immune environment. Following vaginal infection, CD4+ T cell-derived IFN-γ activates FRT epithelium to produce CXCL9/10 and enhance the migration of antigen-specific effector CD8+ T cells in a CXCR3-dependent fashion.98 Dysbiosis-induced IL-33 production leads to greatly enhanced ILC2 (type 2 innate lymphoid cell) mediated accumulation of eosinophils and defective recruitment of both CD4+ and CD8+ T cells after vaginal herpes virus infection,99 suggesting a potential crosstalk between lower FRT associated microbiome and TRM formation. Different from current paradigm that DCs carry local antigens to the draining LNs to prime antigen-specific naïve T cells, lower FRT mucosa is able to support naïve CD8+ T cell priming and proliferation in situ without the involvement of secondary lymphoid organs.100 The significance of mucosa initiated naïve T cell priming remains to be validated in different infection settings. Further, whether different priming sites (i.e., vaginal mucosa versus draining LNs) impact the formation of TRM cells is left to be demonstrated.

Local antigen recognition is not required for FRT TRM differentiation.88 Non-specific local inflammation or exogenous chemokines are sufficient to attract circulating CD8+ T cells and allow newly recruited cells to further differentiate into long-lasting CD69+CD103+ FRT-resident memory T cells.48,101 IL-15 is not required for the homeostasis of FRT TRM population.94 Upon antigenic recall, TRMs quickly produce IFN-γ and function as an alarming system to activate both local innate and adaptive immune components and recruit circulating memory T cells.102,103 CD301b+ LP DCs are required to activate vaginal TRMs upon vaginal herpes virus re-challenge.104 In contrast, dorsal root ganglia resident TRMs are re-activated by recruited monocyte-derived DCs105 and skin CD8+ TRMs are reactivated by almost any directly infected epidermal cells carrying cognate antigens.106 Recent results have demonstrated that FRT TRM cells undergo expansion and differentiation in situ during re-challenge. This TRM-autonomous response dominants the local CD8 recall response. Thus, in addition to a sentinel system, mucosal TRM function as a robust self-sufficient defense system and can function independent of circulating T cells.104,107

Together, the formation and maintenance of FRT TRM are independent of local antigen and IL-15. Different regions of FRT harbor distinct immune environment that impacts CD8+ T cell response. Local DCs are required for the recall response of FRT TRMs. The involvement of TGF-β signaling in FRT TRMs remains to be determined.

E. Non-mucosal tissues

Following systemic infection, kidney supports the differentiation and maintenance of a significant population of both CD69+ and CD69 TRM cells.108 Similar as other non-mucosal TRM cells, most kidney TRM cells do not express CD103. TGF-β is required for the optimal differentiation of kidney TRMs via facilitating effector CD8+ T cell extravasation. Mechanistically, TGF-β signaling promotes the expression of CXCR3 and E/P-selectin ligands on effector CD8+ T cells. Both CXCR3 and E/P-selectin ligands participate in the transendothelium migration of CD8+ effector T cells in the kidney.109 The potential functions of local antigens in kidney TRMs have not been determined. One study has found that kidney TRMs are enriched for T cells with high-affinity TCRs during chronic viral infection,110 suggesting that local antigen may facilitate kidney TRM induction. Common TRM transcriptional program is active in kidney TRM cells as deficiency in transcription factors Blimp-1, Hobit or Runx3 leads to impaired maintenance of kidney TRM cells.111,112 Similar to skin, lung and salivary gland TRM cells, the long-term maintenance of kidney TRM cells is IL-15-dependent.60,94 However, the protective function of kidney TRM cells remains to be demonstrated. During polyomavirus BK reactivation following kidney transplant in human patients, the presence of CD69+ kidney TRM cells is associated with diminished effector functions and poor virus control while CD69 kidney CD8+ T cells are associated with better clinical outcomes.113 Together, TGF-β promotes the formation of kidney TRMs. IL-15 is required for the long-term survival of kidney TRMs while the protective function of kidney TRMs remains to be determined.

Even though considered as a non-mucosal tissue, salivary gland supports the differentiation and maintenance of a significant population of CD69+CD103+ intraepithelial CD8+ TRM cells. Similar as intestinal mucosal, but distinct from most other tissues which have been examined, the differentiation of salivary gland TRM does not require cognate antigen recognition.114116 Local inflammation does not affect TRM differentiation in salivary gland as least during murine cytomegalovirus infection. Integrin α4β1 is required for the accumulation of CD8+ T cells in the salivary gland mediated via the interaction with endothelial VCAM-1 (Vascular Cell Adhesion Molecule-1).115,117 Often used as an epithelium marker, E-cadherin is highly expressed by salivary gland TRM and promotes CD8+ T cell accumulation presumably via homotypic interactions between E-cadherin.116 TGF-β signaling is required for the induction of CD103 and long-term maintenance of salivary gland TRMs. Similar as the situation for intestinal TRM cells, CD103 itself is only involved in the initial establishment, but not long-term maintenance of salivary gland TRMs. Thus, CD103-independent but TGF-β-dependent mechanisms may be essential for the maintenance of TRM cells. The initial induction of CD69 is TGF-β- and type I IFN-independent and may involve the signals from IL-33 and TNF.114,118 IL-15 is not required for the initial differentiation,114 but essential for the long-term survival of salivary gland TRMs.94 In summary, initial CD69 induction on salivary gland TRMs is independent of local antigen and TGF-β. The long-term maintenance of TRMs requires both TGF-β and IL-15. Adhesion molecules including integrin α4β1, CD103 and E-cadherin promote the accumulation of salivary gland TRMs.

Home to a large collection of diverse immune cell types, liver has been proposed as a lymphoid organ and functions as an essential battle field against various liver-targeting pathogens, such as malaria, hepatitis B and hepatitis C virus.119 Murine liver TRM cells are identified as CD69+CXCR6+CXCR3+CD11a+CD103.120,121 In contrast to most TRM cells that are located outside the vasculature, the vast majority of liver TRM cells reside inside the blood vessels and display active crawling behavior to patrol hepatic sinusoids.108,120122 This unique feature excludes the usage of intravascular labeling technique in liver TRM research. Even constantly exposed to blood circulation, liver TRM are not travelling along the bloodstream and considered as bona fide liver-resident cells as demonstrated by parabiosis experiments. Their liver residency is dependent on integrin LFA-1 (Lymphocyte Function-associated Antigen-1) and chemokine receptor CXCR3.120,121 Local antigen is required for liver TRM formation. At the transcription level, both Blimp-1 and Hobit are required for the maintenance of liver TRM in mouse.111 However, liver TRM isolated from human hepatitis B virus infected patients display a Blimp-1hiHobitlo phenotype.123 In contrast to the situation that most mouse liver TRMs are CD103, a distinct CD69+CD103+ TRM population is present in human liver. TGF-β together with IL-15 may mediate liver TRM formation in human. However, the function of TGF-β in mouse liver TRM has not been determined. Regarding the effector functions, both human and mouse liver TRMs are associated with enhanced local protection. Interestingly, in response to TLR4 or TLR9 signals, inflammatory monocytes forms cocoon-like cell aggregates in mouse liver to support local proliferation of CD8+ T cells. These cellular structures may represent a key site for liver TRM function.124 Human liver TRMs display an IFN-γhi IL-2hi GranzymeBlo phenotype123 while mouse liver TRMs are GranzymeBhi IFN-γhi 120 and produce colony-stimulating factor-2.84 In addition to the species difference, various infection settings may also contribute to the phenotypic and functional distinctions in liver TRM populations. Together, liver TRMs are closely associated with blood vasculature. Local antigen recognition is required for the induction of liver TRMs. LFA-1 and CXCR3 promote liver TRM formation. The requirement of TGF-β signaling remains to be determined. Prominent distinctions have been identified between mouse and human TRMs in the liver.

Following local infection, CD8+ effector T cells migrate to the brain and differentiate into both CD69+CD103 and CD69+CD103+ TRM cells.125,126 Local antigen presentation is required for the differentiation of brain TRM cells, consistent with the findings that during persistent brain infection, the TCR affinity of brain TRM cells gradually increases.110 TGF-β signaling likely promotes the induction of CD103+ brain TRM cells as depletion of Foxp3+ regulatory T cells (Tregs) and Treg-derived TGF-β impairs the formation of brain TRM population.127 Further, similar as kidney TRM cells, TGF-β promotes the trans-endothelial migration of CD8+ effector T cells into the brain.109 Locally produced survival cytokines IL-7 and/or IL-15 may promote brain TRM homeostasis as a sizable population of brain TRMs contains phosphorylated STAT5 and undergoes homeostasis proliferation in vivo.128 Interestingly, pSTAT5+ and proliferating brain TRM cells are enriched around the brain surface comparing with brain parenchyma. However, the cellular source and location of IL-7 and IL-15 have not been determined. Brain TRM cells up-regulate the expression of inhibitory receptors PD-1 and CTLA-4.126 PD-1/PD-L1 interaction is required to limit the accumulation of PD-1hiCD103 CD8+ T cells and promote brain TRM population.129 In contrast to lung and FRT TRMs, the differentiation and maintenance of brain TRM cells are independent of CD4-help.126,128 Cognate antigen re-challenge activates brain TRMs to recruit circulating memory T cells. However, in the absence of circulating memory T cells, activated brain TRM cells proliferate in situ and provide sufficient immune protection.128 Thus, in addition to functioning as a component of local alarming system, brain TRMs can function as an organ-autonomous defense system. Together, brain TRM induction depends on local antigen encounter and is independent of CD4-help. TGF-β promotes TRM formation and IL7/15 may provide the survival signals for TRMs in the brain.

In response to oral infections, mesenteric white adipose tissue supports efficient CD69+CD103 TRM differentiation. Surprisingly, white adipose tissue contains more TRM cells and provides better protection than intestinal LP against intestinal infections.130 White adipose tissue TRM cells carry the receptors for survival cytokines IL-15 and IL-7. However, the local signals which drive the differentiation and maintenance of while adipose tissue TRM remains unknown. Considering the unique metabolic requirement of TRM cells, i.e., the uptake of exogenous lipid,54 white adipose tissue may provide an ideal environmental niche for TRMs.

With proper infection settings, almost all non-lymphoid organs support the differentiation of TRM cells. Different microenvironment and local signals dictate the phenotype and behavior of TRM cells isolated from various tissues. The tissue specific features of CD8+ TRM isolated from various non-lymphoid organs are summarized in Table 1. Be aware that when TRM is studied in different tissues, it is often involved distinct infection models. Therefore, in addition to tissue-specific local environment, infection-specific properties may also impact TRM cells.

Table 1.

Tissue-specific features of CD8+ TRMs.

Local Ag TGF-β IL-15 Xcr-1+DC CD4-help Unique Effector
Skin N.R., but promote Required* Required Required N.R. ? IL-17 from a subset
Lung Required Required* Required Required Required IL-22
URT N.R. N.R. Unknown Unknown Unknown Unknown
SI N.R./Suppress Required* N.R. Unknown Unknown Type I/III IFN
FRT N.R. Unknown N.R. Unknown Required Unknown
Kidney Unknown Promote Required Unknown Unknown Unknown
SG N.R. Required* Required Unknown Unknown Unknown
Liver Required Maybe Maybe Unknown Unknown CSF-2
Brain Required Maybe Maybe Unknown N.R. Unknown
WAT Unknown Unknown Maybe Unknown Unknown Unknown

URT, Upper respiratory tract; SI, Small intestine; FRT, Female reproductive tract; SG, Salivary gland; WAT, White adipose tissue.

Ag, Antigen; N.R., not required.

*

, TGF-β is required for CD103+ TRM, but not for CD69+CD103 TRM.

?

, The involvement of CD4-help in skin TRM formation may require future investigation.

II. Transcriptional regulation of TRM cells

Transcription factors (TFs) control the development of multiple immune cell types through activating and/or repressing genes that are critical to cell identity.131 Comparing with effector and memory T cells in lymphoid tissues and circulation, TRM cells in non-lymphoid tissues are a unique and distinct memory T cell population that displays a specific TF expression pattern. TRM cell fate is determined by the integrated activity of multiple TFs, which contributes to optimal survival and function within their local environment.132 Functional illumination of TFs-modulated TRM formation will facilitate future manipulation of these TFs to foster TRM accumulation, which ultimately yield desirable and effective protective memory T cells in tissues. In this section, TFs with a well-established role in TRM formation are discussed in details below.

A. Krüppel-Like Factor 2 (KLF2)

Krüppel-like factors (KLFs) are a family of zinc-finger TFs including 15 mammalian family members, in which Klf2 is one of the core transcriptional regulators that affect T cell trafficking.133,134 The reduction of Klf2 is required to establish tissue-residency of various immune cells, including mouse and human CD8+ TRM,46,86,111 CD4+ TRM,135 NK and NKT cells,111,136 and CD8αα+ TCRαβ T cells and TCRγδ T cell in the IEL compartment of the gut.137 As a possible exception to the universal down-regulation of Klf2 in tissue-resident lymphocytes, a significant population of conventional TCRαβ T cells (both CD4+ and CD8β+) in the IEL compartment of the large intestine, but not in that of the small intestine maintain a high level of Klf2 expression.137 The biological significance of this unique expression pattern of Klf2 in large intestine IEL remains unclear. Klf2 controls the expression of receptors required for emigration and peripheral trafficking, including S1pr1, CD62L, CCR7 and β7 integrin.133 Once entry into peripheral non-lymphoid tissues, local cytokines such as TGF-β, IL-33 and TNF cooperate to extinguish the expression of both Klf2 and its target S1pr1, which potentiates the retention of TRM cells in the tissue.46,75,88 Mechanistically, PI3K/Akt pathway is activated by cytokine signals to inhibit the expression of transcription factor Foxo1 and therefore enforce the down-regulation of K1f2 46 Various combinations of pro-inflammatory cytokines can suppress the expression of Klf2 in activated CD8+ T cells in vitro, including type I IFN, IL-12 and IL-18.46,88 However, type I IFN does not significantly alter TRM differentiation44 and IL-12 inhibits early differentiation and promotes long-term maintenance of gut TRM.89 Thus, the function of different cytokines in TRM cells will require further clarification in different tissues under various inflammatory conditions in vivo. TCR signal is not involved in the down-regulation of Klf2 during acute viral infections. In summary, as a key regulator of T cell trafficking, local cytokine-mediated repression of Klf2 is essential to establish tissue residency of most TRMs.

B. T-bet and Eomes

T-bet (encoded by Tbx21) and Eomesodermin (encoded by Eomes), as two members of T-box binding TFs, are essential regulators for the differentiation and function in distinct immune cells including CD4+ T, CD8+ T, NKT, NK, innate lymphocytes and B cells.138 In CD8+ T cells, Tbx21 expression is highest in short-lived effector cells, whereas Eomes expression is increased in long-lived memory cells.139 Temporal and spatial down-regulation of both Tbx21 and Eomes represents a pivotal step in the lodging and maturation of skin TRM cells, in which Eomes is virtually extinguished, either before or after CD8+ T cells enter the epithelium and prior to the acquisition of CD103.60 However, Tbx21 deficient CD103+CD8+ TRM cells ultimately vanish over time, because complete loss of Eomes during the final maturation of CD103+CD8+ TRM cells renders them dependent on low level of T-bet for persistent survival. This phenomenon is supported by the notion that at least one T-box TF, in particular T-bet, is necessary to maintain the expression of cytokine receptor subunit CD122 (IL-2/IL-15R β chain), which delivers a survival signal to certain memory T cell populations.60,140,141 However, the requirement of IL-15 in the long-term survival of TRMs is tissue type-dependent.94 Whether IL-15-independent TRMs requires residual expression of CD122 and T-bet remains to be clarified. In addition, complete lack of T-box TFs in CD8+ T cells may lead to the activation of RORγt-mediated type 17 effector program. The transcriptional regulation of type 17 CD8+ effectors is not entirely understood.

Smad3 is required for TGF-β mediated CD103 (encoded by Itgae) expression. Both Smad3 and T-bet directly bind to the first intron of Itgae locus, suggesting the potential mechanisms by which T-bet might repress Itgae transcription. T-bet may directly compete with Smad3 for DNA binding, interact with Smad3 to prevent its transcription, or recruit other transcriptional repressors to the Itgae locus.42 Further, the well-orchestrated down-regulation of both T-bet and Eomes strengthens TGF-β signaling pathway that reciprocally inhibits the expression of T-bet and Eomes, indicating a feed-forward loop forms to optimize CD103+CD8+ TRM cell formation.60 Interestingly, previous reports have documented that enhanced T-bet expression and defective TRM formation are often associated in various scenarios. CD8+ T cell priming in the absence of CD4 help,42 deficiency in cross-Priming DCs37 or in infant animals and human142 all lead to increased T-bet expression and defective TRM formation. The common factors controlling T-bet expression in above-mentioned settings remain unknown. In addition to TGF-β and IL-15, other signals that control the expression of T-bet and Eomes during TRM differentiation remain to be discovered.

TGF-β signaling pathway is composed of a complicated network of molecular interactions.143 Briefly, upon ligand binding, TGF-β receptor complex phosphorylates Smad2 and Smad3. Phosphorylated Smad2/3 associate with Smad4 and translocate to the nucleus. In addition to TGF-β, other members of TGF-β superfamily can also activate Smad (e.g., Activins and Bone Morphogenetic Proteins). For instance, Smad4-mediated Myc expression is essential for T cell homeostasis and function via a TGF-β-independent and presumably other TGF-β superfamily member(s)-dependent fashion.144 Except for Smad4, other factors, such as Tripartite Motif Containing 33 (encoded by Trim33) can cooperate with phosphorylated Smad2/3 to initiate transcription.145 Further, TGF-β also activates non-Smad pathways including MAP kinase pathways, Rho-like GTPase and PI3K/Akt pathways.146 Accumulating evidence suggest that TGF-β does not control TRM differentiation via the canonical Smad4-dependent pathway. Indeed, Smad4 deficient and TGF-β unresponsive CD8+ T cells exhibit opposite phenotypes during TRM differentiation. Smad4 deficient CD8+ T cells exhibit dramatically enhanced differentiation of CD103+TRM cells comparing with TGF-β unresponsive CD8+ T cells that fail to up-regulate CD103 under similar settings.68 Similarly, TGF-β and Smad4 antagonize each other during Th17 differentiation in CD4+ T cells. TGF-β signaling reverses Smad4-mediated suppression of RORγt via a SKI-dependent mechanism.147 Whether similar mechanisms are underlying TGF-β-induced TRM differentiation remains to be demonstrated. In addition, TGF-β regulates several T cell-related target genes (e.g., Eomes and RORγt) in a Smad2/3-independent manner.148,149 TGF-β represses the expression of Klf2 via the non-Smad PI3K/Akt pathway.46 However, direct genetic evidence to support a TGF-β-dependent and Smad-independent mechanism in TRM differentiation remains to be established. Considering the importance of TGF-β in Th17 CD4+ T cell differentiation, it is interesting to determine the role of TGF-β in type 17 CD8+ TRM cells and the interconnected regulation between TGF-β, T-bet, Eomes and RORγt. Together, considering the facts that Smad3 directly binds to Itgae locus, TGF-β may control the differentiation and homeostasis of TRMs via both Smad2/3-dependent and Smad-independent pathways.

C. Blimp1 and Hobit

Homolog of B lymphocyte-induced maturation protein (Blimp1) in T cells (Hobit, encoded by Zfp683 or Znf683) and Blimp1 (encoded by Prdm 1) play a universal role in tissue residency of distinct immune cells.111 In CD8+ T cells, Blimp1 is increased in effector cells and important for efficient effector function and terminal differentiation, whereas Hobit shows relatively low expression in effector and circulating memory CD8+ T cells.150 In contrast, Hobit expression is specifically up-regulated in TRM cells including CD8+, ILC1 and NKT cells from different anatomical sites. Transcriptional analysis indicates that both Blimp1 and Hobit deletion in CD8+ T cells re-activates genes associated with tissue egress including Ccr7, S1pr1 and Klf2, which in turn enhances the ability of T cells to exit from peripheral tissues and abolishes tissue residency. Deficiency in either Blimp1 or Hobit leads to partial reduction of CD8+ TRM cells, while simultaneously abolishing both Blimp1 and Hobit near-completely inhibits the formation of CD8+ TRM cells in diverse organs including the skin, liver, gut and kidney, suggesting the synergistic function of both TFs is required to establish tissue residency.111

In contrast to the situation in mouse TRM, the function of Hobit in human is less clear. The unique induction of Hobit in TRM cells is only observed in mouse. Human TEM cells express a significant level of Hobit. Therefore, even though most other TRM core signature genes are highly conserved between mouse and human, the function of Hobit in human TRMs may require additional evidence.70,123,151153

D. Runx3

Runx protein family (Runx1, 2 or 3) has a unique DNA-binding α subunit, which forms a complex with cofactor CBFβ (Core-binding factor subunit β) that stabilizes the Runx-DNA interaction.154 As DNA-binding TFs, Runx proteins control thymocyte differentiation and determine the fate of CD4+ and CD8+ T cell lineages. Specifically, Runx3 represses TF Th-Pok (encoded by Zbtb7b), therefore inhibits CD4 lineage potential and contributes to the development of CD8+ single-Positive thymocytes.155,156 Further, Runx3 induces the expression of CD103 in CD8+ single-Positive thymocytes. Synergizing with T-bet and Eomes, Runx3 is required to maintain the cytotoxicity program of activated CD8+ T cells via transcriptional regulation of key effectors including IFN-γ, perforin and granzyme B.157,158 In addition, Runx3 deploys epigenetic marks (i.e., H3K27me3) to guard the fate of effector CD8+ T cells and prevent the expression of follicular helper T cell-related genes.159 As to be discussed in the next section, a small population of CD4+ T cells acquire the expression of Runx3 and differentiate into CD8αα+ CD4+ TRM cells in the gut IEL compartment.160,161 More recently, using computational and pooled in vivo RNAi screens, Runx3 is reported to be a critical regulator in the establishment of TRM cell populations in both non-barrier tissues (salivary gland and kidney) and barrier tissues (IEL, skin and lung parenchyma) even though the expression of Runx3 is not specifically induced in TRM cells. Runx3 supports the expression of tissue-residency genes and represses genes associated with egress and recirculation. In addition, Runx3 is also a driver for both human and mouse CD8+ tumor-infiltrating lymphocytes (TILs) that exhibit characteristics of TRM cells.112

E. Other TFs and Perspectives

Nur77 (encoded by Nr4a1), together with Nurr1 (encoded by Nr4a2) and NOR-1 (encoded by Nr4a3), constitute the NR4A subfamily of orphan nuclear receptors in the steroid thyroid receptor family.162 In the thymus, Nur77 controls CD8+ T cell development by suppressing the expression of Runx3.163 In the periphery, as an immediate early response gene downstream of TCR signaling, Nur77 regulates CD8+ T cell expansion and effector function through transcriptional repression of Irf4. Lack of Nur77 leads to enhanced CD8+ T cell expansion, especially in KLRG-1+ terminally differentiated effector cells.164 T cells from Nr4a1−/− mice display reduced capacity to generate TRM cells, suggesting the potential role of Nur77 in the generation and/or tissue residency of TRM cells. Interestingly, at memory phase of influenza infection, lung and liver TRM cells exhibit a 2 to 4 fold reduction while gut IEL TRMs display a 90 fold decrease in the absence of Nur77 expression. The mechanisms leading to this dramatic tissue-specific requirement of Nur77 remain unclear.165 Notably, under different infection settings, both lung and liver TRMs, but not gut TRMs require local antigen recognition. The connection between local TCR signal and the requirement of Nur77 in TRMs remains to be visited in the future.

The expression of Notch and its down-streaming TF recombination signal binding protein for immunoglobulin kappa J (encoded by Rbpj) is enriched in human and mouse lung CD103+ TRM cells. Simultaneous disruption of both Notch1 and Notch2 in T cells results in a two-fold reduction in CD103+ TRM cells in the lung after influenza virus infection. Activation of Notch signaling pathway promotes the persistence of CD103+ TRM cells via controlling metabolic programs.70 The involvement of Notch signals in TRM cells isolated from other tissues is largely unknown.

Further, the targeting genes of hypoxia-inducible factor-1α (HIF-1α) are significantly enriched in human lung TRM cells.70 Interestingly, oxygen-sensing prolyl-hydroxylase (PHD) proteins degrade HIF-1α via their enzymatic activity. Disruption of PHD proteins in T cells results in elevated HIF-1α expression and enhanced both CD4+ and CD8+ T cell response specifically in the lung, but not other tissues.166

In addition, arylhydrocarbon receptor (AhR) is required for the maintenance of skin TRM167 and γδ T cells in the epithelial surface and CD8αα+ αβ T cells in the IEL compartments of the gut.168,169

TFs act as a link between signals from extrinsic microenvironment and intrinsic regulation of cellular response. Fluctuations of environmental cues, including cytokines, chemokines, pathogen insult and the persistence of microbiome can modulate the expression of disparate TFs. The cooperation among these TFs in turn instructs T cell differentiation and/or homeostasis. Considering the dramatically variable microenvironment inside different tissues, the knowledge of tissue-specific control of TFs will be essential to understand TRM biology. After leaving the circulation, tissue-specific transcriptional reprogram represents a key step for TRMs to adapt to the new environment and remains largely ill defined. Further, studies of TF cofactors or epigenetic regulators in TRM formation are just in their infancy. These studies will facilitate our understanding of how TFs from the same family, such as T-bet and Eomes, Blimp1 and Hobit, perfoRM both segregated and cooperative functions at the molecular level. In addition, these investigations will help to address the question that how numerous TFs function in a temporal-and spatial-dependent manner.

III. CD4+ TRM cells

The vast majority of recent TRM studies have been focused on CD8+ T cells. CD4+ TRM cells represent a critical adaptive component of local immunity.170 We will use the last section to summarize the recent findings about CD4+ TRM cells in various tissues. We will not include Foxp3+ regulatory T cells in our discussion as recent reviews have covered the related findings.171,172

A. Skin

Early research in mouse has demonstrated that after skin herpes viral infection, CD8+ T cells foRM a distinct population of TRM cells in the epidermis while memory CD4+ T cells are largely located in the dermis and continue to recirculate.32 As unique structure components of the skin, hair follicles produce survival cytokines IL-7 and IL-15, which are essential for the maintenance of skin T cells.53 As a consequence, skin CD4+ T cells are often clustered around hair follicles. Widely used TRM markers CD69 and CD103 are generally believed to contribute to TRM cell retention. Interestingly, even though a significant population of skin CD4+ T cells carry both CD69 and CD103, they reach equilibration with the circulation at steady state, which further questions the function of CD103 in TRM cell biology. Local inflammation promotes CD8+ T cell-and CD11b+ myeloid cell-mediated recruitment and retention of skin CD4+ T cells.173 Therefore, in the absence of local inflammation, skin CD4+ T cells are a component of circulating memory cells even with typical TRM markers.

Different infection models can induce the formation of bona fide skin-resident CD4+ memory T cells. Skin infection of Candida albicans in C57BL/6 mice results in acute infection cleared in less than two weeks. Interestingly, C. albicans infection induces a distinct population of IL-17 producing and largely sessile CD69+CD4+ TRM cells in the superficial layer of the dermis providing C. albicans-specific protection.174 These IL-17+CD4+ TRM cells are often co-localized with CD11c+ dendritic cells months after the clearance of the infection, suggesting a role for residual antigen or inflammatory cues for the retention of skin CD4+ TRM population. Consistent with previous findings that many dermis CD4+ T cells are rapidly exchanging with the blood, a substantial subset of circulating CD4+ T cells is present in the deeper layer of the dermis. These mobile skin CD4+ T cells express low levels of CD69 and do not produce IL-17. These results suggest that different local environment within the dermis can support different subsets of memory CD4+ T cells, including both circulating and tissue-resident cells with distinct effector functions.

Another recent example of skin CD4+ TRM comes from Leishmania major (L. major) infection model in C57BL/6 mice, which leads to prolonged skin lesion that lasts for 12 weeks. After the clearance of the infection, skin CD4+ TRM cells can be identified at both infected and non-infected skin,175 similar as CD8+ TRM cell spreading to non-infected skin after repeated skin infections.33 In contrast to skin CD4+ T cells residing in naïve mice,173 L. major-specific CD4+ TRM cells are not exchanging with circulating cells as demonstrated by grafting infected skin into naïve animals. Consistent with the dermal location of skin CD4+ T cells,32 L. major-specific CD4+ TRM cells are sensitive to antibody-mediated depletion. Functionally, during high dose re-challenge, CD4+ TRM -mediated and IFN-γ-dependent recruitment of circulating memory T cells are required for long-term protection.175 However, during low dose re-challenge, CD4+ TRM and TRM-recruited inflammatory monocytes are sufficient to provide immediate protection without the contribution from circulating T cells.176

Human skin harbors a large number of CD69+CD4+ T cells in the dermis, which is identified as the major TRM population resistant to antibody-mediated depletion. Further, both CD103+CD4+ and CD103+CD8+ T cells are enriched in the epidermis of human skin.31 Keratinocyte derived TGF-β is likely involved in the induction of CD103+CD4+ TRM cells in human. However, genetic evidence to support a role of TGF-β in skin CD4+ TRMs in mouse is missing.

Strictly speaking, bona fide skin CD4+ TRM cells are only formed under certain infection circumstances in mouse. Local inflammatory signals and cognate antigens may regulate the dynamic behavior of skin CD4+ T cells. CD103 is not a reliable marker for skin CD4+ TRM in mouse and the definitive evidence supporting a role of TGF-β in skin CD4+ TRM cell differentiation is lacking.

B. Lung

In both mouse and human lungs, distinct populations of CD4+ T cells carrying typical TRM markers can be identified.27,28,67,152,177,178 Comparing with CD8+ lung TRM, CD4+ TRM cells usually carry less CD103 or express CD11a instead of CD103.170,178,179 Genome wide transcriptional analysis reveals that CD4+ lung TRM cells resemble CD8+ lung TRM cells.151,152,179 Similar transcription programs including the down-regulation of T-bet and Eomes, and the up-regulation of Blimp-1 and Notch signaling, direct the local differentiation of lung CD4+ TRM cells.152 Interestingly, human and mouse infant T cells (including both CD4+ and CD8+ T cells) express enhanced levels of T-bet and exhibit defective lung TRM cell formation, further suggesting that down-regulation of T-bet is a conserved common mechanism underlying both CD4+ and CD8+ TRM differentiation.142

Local signals that induce lung CD4+ TRM cells are not entirely known. Similar as CD4+ TRM clusters in the skin and vagina, clusters of lung CD4+ TRM have been identified after influenza virus infection,170 suggesting a common mechanism underlying CD4+ TRM differentiation and/or maintenance. In contrast to lung CD8+ TRM cells, one report has suggested that mouse lung CD4+ TRM is TGF-β-independent, consistent with a CD103 phenotype. Distinct from CD103+CD8+ TRM, IL-15 is required during the early differentiation, but not the long-term maintenance of CD4+ lung TRM cells in mouse.179 Following both acute viral infection (a Th1 response) and brief allergy exposure-induced lung inflammation (a Th2 response), a clear population of lung-resident antigen-specific CD4+ T cells that is separated from bloodstream forms in an IL-2-dependent manner and play essential functions in local immunity.180,181 In response to prolonged allergen exposure, a similar CD69+ and Th2-biased CD4+ TRM population persists in the lung parenchyma.182 Even in the absence of circulating T cells, these CD4+ TRMs are sufficient to mount a robust recall response. Similar autologous recall response has also been observed for helminth-induced lung CD4+ TRMs after T cell migration has been blocked.183 Together, similar as lung CD8+ TRM cells, lung CD4+ TRM cells are formed under various infectious and inflammatory settings. However, the cellular and molecular mechanisms underlying their differentiation and long-term maintenance remain to be demonstrated.

C. Other Non-lymphoid Tissues

Murine cytomegalovirus infection induces a distinct population of CD69+CD4+ TRM cells in the salivary gland. In contrast to antigen-independent differentiation of CD8+ TRM cells in the same tissue and same infection model, CD4+ TRM formation requires local antigen in the salivary gland.114 The role of TGF-β in salivary gland CD4+ TRM remains undetermined.

In both naïve and mucosal infected mice, CD69+CD103CD4+ TRM cells are identified in the white adipose tissue and provide potent protective response.130 White adipose tissue CD4+ TRM cells are isolated from circulation as demonstrated by parabiosis experiments. Further, they carry mucosal homing integrin α4β7.130 Considering that TGF-β inhibits integrin α4β7 expression on effector CD8+ T cells,90 it will be interesting to test the involvement of TGF-β signaling in white adipose tissue CD4+ TRM.

Further, genital mucosa supports CD4+ TRM cell differentiation after herpes simplex virus infection. Similar as skin and lung CD4+ TRM cells, genital CD4 TRM cells foRM clusters.135 In contrast to the more mobile behavior of skin CD4+ TRM cells isolated from mouse dermis, vaginal CD4+ TRM cells are locally restricted and isolated from the circulation. Remarkably, even mucosal vaccination at a remote site (i.e., intra nasal priming) induces protective CD4+ TRM formation at vaginal mucosa in a Chlamydia infection model. Similar as CD8+ TRM cells, vaginal CD4+ TRM differentiation is limited to the early stage of effector phase when a large number of activated T cells exit secondary lymphoid organs and migrate to peripheral mucosal sites.184 The relationship between TGF-β and the differentiation of CD4+ TRM in FRT remains unknown.

Comparing with CD8+ TRMs, CD4+ TRMs are a minor cell population within the IEL compartment of the small intestines in naïve specific pathogen free mice.21 Most of these unique CD4+ TRM cells carry surface expression of CD 8αα. Both conventional effector and regulatory CD4+ T cells can differentiate into IEL CD8αα+ CD4+ TRM cells in response to specific microbiota stimulation.185 In addition, gut enriched local signals, such as TGF-β and retinoic acid are essential for the differentiation of CD8αα+CD4+ TRM cells in the IEL compartment. The down-regulation of lineage specific TF Th-POK (conventional CD4+) or Foxp3 (Treg) and the up-regulation of TRM and CD8+ related TF Runx3 are crucial for their differentiation.160,161,186

Distinct from microbiota-induced CD8αα+CD4+ TRM cells, listeria oral infection leads to the differentiation of CD4+ gut TRM cells without the surface expression of CD 8aa. These CD4+ TRM cells carry CD69 and reside in both IEL and LP compartments.187 A small percentage of IEL CD4+ TRM cells also express CD103. These gut CD4+ TRMs provide essential Th1 response-mediated protection against re-infection and maintained in an IL-15-independent manner, similar as gut CD8+ TRM cells. Intestine-restricted helminth infection induces a large population of Th2 CD4+ memory T cells in both gut LP compartment and peritoneal cavity. However, whether these protective Th2 memory CD4+ T cells are bona fide TRMs remains elusive.188

Together, consistent with the complexity and plasticity of effector CD4+ T cell differentiation programs, different local signals drive the differentiation of distinct CD4+ TRM cells at the intestinal mucosal surface.

D. Secondary Lymphoid Tissues

A series of recent discoveries have demonstrated that a significant population (up to 50%) of CD44hi effector/memory CD4+ T cells reside in secondary lymphoid organs (i.e., spleen, LNs and Peyer’s patches) without continuous recirculation for a prolonged period of time.26,189191 Similar as TRM isolated from non-lymphoid organs, these secondary lymphoid organ CD4+ TRM express higher levels of CD69 and lower levels of S1pr1 than their circulating counterparts. In contrast to the widely accepted notion that secondary lymphoid organs are mainly occupied by circulating T cells, antigen-specific CD4+ memory T cells residing in the draining lymph nodes are largely sessile after immunization.191 Further, similar CD4+ TRM cells are present in the secondary lymphoid organs of naïve specific pathogen free mice presumably due to prolonged TCR stimulation by self-antigens and microbiome-derived antigens. The population of secondary lymphoid organ CD4+ TRM expands with age.26 Interestingly, a significant population of secondary lymphoid organ CD4+ T cells express TRM marker CD69 in adult human.151 These secondary lymphoid organ TRMs may represent a conserved phenomenon in CD4+ T cell biology although the functional importance and molecular control of these CD4+ TRMs remain to be determined.

In summary, with unique tissue-specific features, CD4+ TRM cells are present in a variety of lymphoid and non-lymphoid tissues, and play a non-redundant function in local immunity. Considering the complexity of effector CD4+ T cell lineages, the differentiation and maintenance of CD4+ TRM cells may be controlled in a tissue-specific and inflammation-specific manner while preserve a common gene signature that restricting the recirculation. TGF-β controls the differentiation of almost every individual lineage of effector CD4+ T cells under certain conditions. However, the contribution of TGF-β signal to CD4+ TRM cells remains largely unknown presumably due to the difficulties to dissect the roles of TGF-β in tissue residency from those in effector CD4+ lineage specification.

Conclusions

TRM cells represent a major memory T cell population without continuous recirculation. Recent advances have established that common transcriptional and metabolic programs distinguish TRM cells from circulating T cells and are closely associated with the behavior and function of TRM cells. In various infection settings, it has been demonstrated that TRM cells can function both as an alarming system and a self-sufficient defense system without significant contribution from circulating T cells, which further emphasize the importance of inducing desired TRM populations in future vaccine design.

In addition to the common differentiation programs, to establish residency in different tissues, TRM cells are required to adapt tissue-specific programs to accommodate unique local environmental cues. Recent investigations have accumulated evidence to support the paradigm that local signals, including cognate antigens, TGF-β, survival and inflammatory cytokines may impact TRM cells in a tissue-specific and infection-specific manner. The mechanisms underlying tissue-specific TRM regulation remain largely unknown. Even within a given tissue, the microenvironment is not homogenous. Thus, it is conceivable that the heterogeneity of TRM population in a given tissue may be tightly linked with their functions. Together, studies on the intercellular and intracellular programs that are induced by local environmental signals may provide important information to deepen our understanding of TRM biology and guide the development of TRM-focused future vaccine strategies.

Acknowledgements

N.Z. is supported by National Institute of Health Grant R01-AI125701 and Young Investigator Award from Max and Minnie Tomerlin Voelcker Fund.

Glossary

TCM

Central memory T cell

DC

Dendritic cell

TEM

Effector memory T cell

FRT

Female reproductive tract

IEL

Intraepithelial lymphocyte

LP

Lamina propria

LN

Lymph node

TCR

T cell receptor

TRM

Tissue-resident memory T cell

TF

Transcription factor

TGF-β

Transforming growth factor-β

VACV

Vaccinia virus

Footnotes

Conflict of Interest

The authors declare no competing financial interests.

Reference:

  • 1.Jenkins MK, Chu HH, McLachlan JB & Moon JJ On the composition of the preimmune repertoire of T cells specific for Peptide-major histocompatibility complex ligands. Annu Rev Immunol 28, 275–294, doi: 10.1146/annurev-immunol-030409-101253 (2010). [DOI] [PubMed] [Google Scholar]
  • 2.Mackay CR, Marston WL & Dudler L Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 171, 801–817 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhang N & Bevan MJ CD8(+) T cells: foot soldiers of the immune system. Immunity 35, 161–168, doi: 10.1016/j.immuni.2011.07.010 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Williams MA & Bevan MJ Effector and memory CTL differentiation. Annu Rev Immunol 25, 171–192, doi: 10.1146/annurev.immunol.25.022106.141548 (2007). [DOI] [PubMed] [Google Scholar]
  • 5.Ahmed R, Bevan MJ, Reiner SL & Fearon DT The precursors of memory: models and controversies. Nat Rev Immunol 9, 662–668, doi: 10.1038/nri2619 (2009). [DOI] [PubMed] [Google Scholar]
  • 6.Akondy RS, Fitch M, Edupuganti S, Yang S, Kissick HT, Li KW, Youngblood BA, Abdelsamed HA, McGuire DJ, Cohen KW, Alexe G, Nagar S, McCausland MM, Gupta S, Tata P, Haining WN, McElrath MJ, Zhang D, Hu B, Greenleaf WJ, Goronzy JJ, Mulligan MJ, Hellerstein M & Ahmed R Origin and differentiation of hum an mem ory CD8 T cells after vaccination. Nature 552, 362–367, doi: 10.1038/nature24633 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Youngblood B, Hale JS, Kissick HT, Ahn E, Xu X, Wieland A, Araki K, West EE, Ghoneim HE, Fan Y, Dogra P, Davis CW, Konieczny BT, Antia R, Cheng X & Ahmed R Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552, 404–409, doi: 10.1038/nature25144 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sallusto F, Lenig D, Forster R, Lipp M & Lanzavecchia A Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712, doi: 10.1038/44385 (1999). [DOI] [PubMed] [Google Scholar]
  • 9.Obar JJ & Lefrancois L Memory CD8+ T cell differentiation. Ann N Y Acad Sci 1183, 251–266, doi: 10.1111/j.1749-6632.2009.05126.x (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Osborn JF, Mooster JL, Hobbs SJ, Munks MW, Barry C, Harty JT, Hill AB & Nolz JC Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8(+) T cells. Sci Immunol 2, eaan6049 doi: 10.1126/sciimmunol.aan6049 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nolz JC & Harty JT IL-15 regulates mem ory CD8+ T cell O-glycan synthesis and affects trafficking. J Clin Invest 124, 1013–1026, doi: 10.1172/JCI72039 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Abboud G, Desai P, Dastmalchi F, Stanfield J, Tahiliani V, Hutchinson TE & Salek-Ardakani S Tissue-specific program m ing of memory CD8 T cell subsets impacts protection against lethal respiratory virus infection. J Exp Med 213, 2897–2911, doi: 10.1084/jem.20160167 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mueller SN & Mackay LK Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol 16, 79–89, doi: 10.1038/nri.2015.3 (2016). [DOI] [PubMed] [Google Scholar]
  • 14.Clark RA Resident memory T cells in human health and disease. Sci Transl Med 7, 269rv261, doi: 10.1126/scitranslmed.3010641 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mueller SN, Gebhardt T, Carbone FR & Heath WR Memory T cell subsets, m igration patterns, and tissue residence. Annu Rev Immunol 31, 137–161, doi: 10.1146/annurev-immunol-032712-095954 (2013). [DOI] [PubMed] [Google Scholar]
  • 16.Park CO & Kupper TS The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 21, 688–697, doi: 10.1038/nm.3883 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Iijima N & Iwasaki A Tissue instruction for migration and retention of TRM cells. Trends Immunol 36, 556–564, doi: 10.1016/j.it.2015.07.002 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Schenkel JM & Masopust D Tissue-resident mem ory T cells. Immunity 41, 886–897, doi: 10.1016/j.immuni.2014.12.007 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Thome JJ & Farber DL Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol 36, 428–435, doi: 10.1016/j.it.2015.05.003 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cauley LS & Lefrancois L Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 6, 14–23, doi: 10.1038/mi.2012.96 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cheroutre H, Lambolez F & Mucida D The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11, 445–456, doi: 10.1038/nri3007 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Li MO & Flavell RA TGF-beta: a m aster of all T cell trades. Cell 134, 392–404, doi: 10.1016/j.cell.2008.07.025 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Travis MA & Sheppard D TGF-beta activation and function in immunity. Annu Rev Immunol 32, 51–82, doi: 10.1146/annurev-immunol-032713-120257 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kilshaw PJ & Murant SJ A new surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol 20, 2201–2207, doi: 10.1002/eji.1830201008 (1990). [DOI] [PubMed] [Google Scholar]
  • 25.Schenkel JM, Fraser KA & Masopust D Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs. J Immunol 192, 2961–2964, doi: 10.4049/jimmunol.1400003 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Durand A, Audemard-Verger A, Guichard V, Mattiuz R, Delpoux A, Hamon P, Bonilla N, Riviere M, Delon J, Martin B, Auffray C, Boissonnas A & Lucas B Profiling the lym phoid-resident T cell pool reveals modulation by age and microbiota. Nat Commun 9, 68, doi: 10.1038/s41467-017-02458-4 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Thome JJ, Yudanin N, Ohmura Y, Kubota M, Grinshpun B, Sathaliyawala T, Kato T, Lerner H, Shen Y & Farber DL Spatial map of human T cell com partm entalization and m aintenance over decades of life. Cell 159, 814–828, doi: 10.1016/j.cell.2014.10.026 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wong MT, Ong DE, Lim FS, Teng KW, McGovern N, Narayanan S, Ho WQ, Cerny D, Tan HK, Anicete R, Tan BK, Lim TK, Chan CY, Cheow PC, Lee SY, Takano A, Tan EH, Tam JK, Tan EY, Chan JK, Fink K, Bertoletti A, Ginhoux F, Curotto de Lafaille MA & Newell EW A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures. Immunity 45, 442–456, doi: 10.1016/j.immuni.2016.07.007 (2016). [DOI] [PubMed] [Google Scholar]
  • 29.Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC & Masopust D Normalizing the environment recapitulates adult hum an immune traits in laboratory mice. Nature 532, 512–516, doi: 10.1038/nature17655 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Beura LK, Wijeyesinghe S, Thompson EA, Macchietto MG, Rosato PC, Pierson MJ, Schenkel JM, Mitchell JS, Vezys V, Fife BT, Shen S & Masopust D T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells. Immunity 48, 327–338 e325, doi: 10.1016/j.immuni.2018.01.015 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.W atanabe R, Gehad A, Yang C, Scott LL, Teague JE, Schlapbach C, Elco CP, Huang V, Matos TR, Kupper TS & Clark RA Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7, 279ra239, doi: 10.1126/scitranslmed.3010302 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, Carbone FR & Mueller SN Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477, 216–219, doi: 10.1038/nature10339 (2011). [DOI] [PubMed] [Google Scholar]
  • 33.Jiang X, Clark RA, Liu L, Wagers AJ, Fuhlbrigge RC & Kupper TS Skin infection generates non-m igratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483, 227–231, doi: 10.1038/nature10851 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, Tscharke DC, Heath WR, Inouye M, Carbone FR & Gebhardt T The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. N atlmmunol 14, 1294–1301, doi: 10.1038/ni.2744(2013). [DOI] [PubMed] [Google Scholar]
  • 35.Zaid A, Hor JL, Christo SN, Groom JR, Heath WR, Mackay LK & Mueller SN Chemokine Receptor-Dependent Control of Skin Tissue-Resident Memory T Cell Formation. J Immunol 199, 2451–2459, doi: 10.4049/jimmunol.1700571 (2017). [DOI] [PubMed] [Google Scholar]
  • 36.Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, Desmarais C, Robins H, Krueger JG, Clark RA & Kupper TS Common clonal origin of central and resident memory T cells following skin immunization. Nat Med 21, 647–653, doi: 10.1038/nm.3860 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Iborra S, Martinez-Lopez M, Khouili SC, Enamorado M, Cueto FJ, Conde-Garrosa R, Del Fresno C & Sancho D Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1(+) Dendritic Cells. Immunity 45, 847–860, doi: 10.1016/j.immuni.2016.08.019 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bevan MJ Cross-Priming. Nat Immunol 7, 363–365, doi: 10.1038/ni0406-363 (2006). [DOI] [PubMed] [Google Scholar]
  • 39.Gutierrez-Martinez E, Planes R, Anselmi G, Reynolds M, Menezes S, Adiko AC, Saveanu L & Guermonprez P Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets. Front Immunol 6, 363, doi: 10.3389/fimmu.2015.00363 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Eickhoff S, Brewitz A, Gerner MY, Klauschen F, Komander K, Hemmi H, Garbi N, Kaisho T, Germain RN & Kastenmuller W Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions. Cell 162, 1322–1337, doi: 10.1016/j.cell.2015.08.004 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hor JL, Whitney PG, Zaid A, Brooks AG, Heath WR & Mueller SN Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection. Immunity 43, 554–565, doi: 10.1016/j.immuni.2015.07.020 (2015). [DOI] [PubMed] [Google Scholar]
  • 42.Laidlaw BJ, Zhang N, Marshall HD, Staron MM, Guan T, Hu Y, Cauley LS, Craft J & Kaech SM CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection. Immunity 41, 633–645, doi: 10.1016/j.immuni.2014.09.007 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ahrends T, Spanjaard A, Pilzecker B, Babala N, Bovens A, Xiao Y, Jacobs H & Borst J CD4(+) T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness. Immunity 47, 848–861 e845, doi: 10.1016/j.immuni.2017.10.009 (2017). [DOI] [PubMed] [Google Scholar]
  • 44.Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, Carbone FR & Gebhardt T Cutting edge: CD69 interference with sphingosine-1-Phosphate receptor function regulates peripheral T cell retention. J Immunol 194, 2059–2063, doi: 10.4049/jimmunol.1402256 (2015). [DOI] [PubMed] [Google Scholar]
  • 45.Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, Cyster JG & Matloubian M CD69 acts dow nstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540–544, doi: 10.1038/nature04606 (2006). [DOI] [PubMed] [Google Scholar]
  • 46.Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA & Jameson SC Transcriptional downregulation of S1pr1 is required for the establishment of resident mem ory CD8+ T cells. Nat Immunol 14, 1285–1293, doi: 10.1038/ni.2745 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Takamura S, Yagi H, Hakata Y, Motozono C, McMaster SR, Masumoto T, Fujisawa M, Chikaishi T, Komeda J, Itoh J, Umemura M, Kyusai A, Tomura M, Nakayama T, Woodland DL, Kohlmeier JE & Miyazawa M Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance. J Exp Med 213, 3057–3073, doi: 10.1084/jem.20160938 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, Mueller SN, Heath WR, Carbone FR & Gebhardt T Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A 109, 7037–7042, doi: 10.1073/pnas.1202288109 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Davies B, Prier JE, Jones CM, Gebhardt T, Carbone FR & Mackay LK Cutting Edge: Tissue-Resident Memory T Cells Generated by Multiple Immunizations or Localized Deposition Provide Enhanced Immunity. J Immunol 198, 2233–2237, doi: 10.4049/jimmunol.1601367 (2017). [DOI] [PubMed] [Google Scholar]
  • 50.Khan TN, Mooster JL, Kilgore AM, Osborn JF & Nolz JC Local antigen in nonlymphoid tissue prom otes resident mem ory CD8+ T cell formation during viral infection. J Exp Med 213, 951–966, doi: 10.1084/jem.20151855 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Muschaweckh A, Buchholz VR, Fellenzer A, Hessel C, Konig PA, Tao S, Tao R, Heikenwalder M, Busch DH, Korn T, Kastenmuller W, Drexler I & Gasteiger G Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells. J Exp Med 213, 3075–3086, doi: 10.1084/jem.20160888 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, Welty NE, Igyarto BZ, Wijeyesinghe S, Thompson EA, Matte C, Bartholin L, Kaplan A, Sheppard D, Bridges AG, Shlomchik WD, Masopust D & Kaplan DH Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-beta. Nat Immunol 17, 414–421, doi: 10.1038/ni.3396 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, Saya H, Amagai M & Nagao K Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med 21, 1272–1279, doi: 10.1038/nm.3962 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O’Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA & Kupper TS Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543, 252–256, doi: 10.1038/nature21379 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song JY, Jacobs H, Haanen JB & Schumacher TN T cell memory. Skin-resident memory CD8(+) T cells trigger a state of tissue-wide pathogen alert. Science 346, 101–105, doi: 10.1126/science.1254803 (2014). [DOI] [PubMed] [Google Scholar]
  • 56.Clark RA, W atanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC & Kupper TS Skin effector memory T cells do not recirculate and provide immune protection in alem tuzum ab-treated CTCL patients. Sci Transl Med 4, 117ra117, doi: 10.1126/scitranslmed.3003008 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Park SL, Zaid A, Hor JL, Christo SN, Prier JE, Davies B, Alexandre YO, Gregory JL, Russell TA, Gebhardt T, Carbone FR, Tscharke DC, Heath WR, Mueller SN & Mackay LK Local proliferation m aintains a stable pool of tissue- resident memory T cells after antiviral recall responses. Nat Immunol 19, 183–191, doi: 10.1038/s41590-017-0027-5 (2018). [DOI] [PubMed] [Google Scholar]
  • 58.Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C, Conlan S, Himmelfarb S, Byrd AL, Deming C, Quinones M, Brenchley JM, Kong HH, Tussiwand R, Murphy KM, Merad M, Segre JA & Belkaid Y Commensaldendritic-cell interaction specifies a unique protective skin immune signature. Nature 520, 104–108, doi: 10.1038/nature14052 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Linehan JL, Harrison OJ, Han SJ, Byrd AL, Vujkovic-Cvijin I, Villarino AV, Sen SK, Shaik J, Smelkinson M, Tamoutounour S, Collins N, Bouladoux N, Dzutsev A, Rosshart SP, Arbuckle JH, Wang CR, Kristie TM, Rehermann B, Trinchieri G, Brenchley JM, O’Shea JJ & Belkaid Y Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell 172, 784–796, doi: 10.1016/j.cell.2017.12.033 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Mackay LK, Wynne-Jones E, Freestone D, Pellicci DG, Mielke LA, Newman DM, Braun A, Masson F, Kallies A, Belz GT & Carbone FR T-box Transcription Factors Combine with the Cytokines TGF-beta and IL-15 to Control Tissue-Resident Memory T Cell Fate. Immunity 43, 1101–1111, doi: 10.1016/j.immuni.2015.11.008 (2015). [DOI] [PubMed] [Google Scholar]
  • 61.Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, W herry EJ, Lindsten T & Reiner SL Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408–411, doi: 10.1126/science.1159806 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Cheuk S, Schlums H, Gallais Serezal I, Martini E, Chiang SC, M arquardt N, Gibbs A, Detlofsson E, Introini A, Forkel M, Hoog C, Tjernlund A, Michaelsson J, Folkersen L, Mjosberg J, Blomqvist L, Ehrstrom M, Stahle M, Bryceson YT & Eidsmo L CD49a Expression Defines Tissue-Resident CD8(+) T Cells Poised for Cytotoxic Function in Human Skin. Immunity 46, 287–300, doi: 10.1016/j.immuni.2017.01.009 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Wu T, Hu Y, Lee YT, Bouchard KR, Benechet A, Khanna K & Cauley LS Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-Protection against pulm onary virus infection. J Leukoc Biol 95, 215–224, doi: 10.1189/jlb.0313180 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Wakim LM, Smith J, Caminschi I, Lahoud MH & Villadangos JA Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection. Mucosal Immunol 8, 1060–1071, doi: 10.1038/mi.2014.133 (2015). [DOI] [PubMed] [Google Scholar]
  • 65.Turner DL, Bickham KL, Thome JJ, Kim CY, D’Ovidio F, Wherry EJ & Farber DL Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol 7, 501–510, doi: 10.1038/mi.2013.67 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Zens KD, Chen JK & Farber DL Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. JCI Insight 1, doi: 10.1172/jci.insight.85832 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Pizzolla A, Nguyen TH, Sant S, Jaffar J, Loudovaris T, Mannering SI, Thomas PG, Westall GP, Kedzierska K & Wakim LM Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest 128, 721–733, doi: 10.1172/JCI96957 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Hu Y, Lee YT, Kaech SM, Garvy B & Cauley LS Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells. J Immunol 194, 2407–2414, doi: 10.4049/jimmunol.1402369 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Zhou AC, Wagar LE, W ortzman ME & Watts TH Intrinsic 4–1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung. Mucosal Immunol 10, 1294–1309, doi: 10.1038/mi.2016.124 (2017). [DOI] [PubMed] [Google Scholar]
  • 70.Hombrink P, Helbig C, Backer RA, Piet B, Oja AE, Stark R, Brasser G, Jongejan A, Jonkers RE, Nota B, Basak O, Clevers HC, Moerland PD, Amsen D & van Lier RA Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells. Nat Immunol 17, 1467–1478, doi: 10.1038/ni.3589 (2016). [DOI] [PubMed] [Google Scholar]
  • 71.Du N, Kwon H, Li P, West EE, Oh J, Liao W, Yu Z, Ren M & Leonard WJ EGR2 is critical for peripheral naive T-cell differentiation and the T-cell response to influenza. Proc Natl Acad Sci U S A 111, 16484–16489, doi: 10.1073/pnas.1417215111 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Yoshizawa A, Bi K, Keskin DB, Zhang G, Reinhold B & Reinherz EL TCR-PMHC encounter differentially regulates transcriptomes of tissue-resident CD8 T cells. Eur J Immunol 48, 128–150, doi: 10.1002/eji.201747174 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Pizzolla A, Nguyen THO, Smith JM, Brooks AG, Kedzieska K, Heath WR, Reading PC & Wakim LM Resident memory CD8(+) T cells in the upper respiratory tract prevent pulm onary influenza virus infection. Sci Immunol 2, doi: 10.1126/sciimmunol.aam6970 (2017). [DOI] [PubMed] [Google Scholar]
  • 74.Wakim LM, Gupta N, Mintern JD & Villadangos JA Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol 14, 238–245, doi: 10.1038/ni.2525 (2013). [DOI] [PubMed] [Google Scholar]
  • 75.Slutter B, Van Braeckel-Budimir N, Abboud G, Varga SM, Salek-Ardakani S & Harty JT Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci Immunol 2, doi: 10.1126/sciimmunol.aag2031 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Ely KH, Cookenham T, Roberts AD & Woodland DL Memory T cell populations in the lung airways are m aintained by continual recruitment. J Immunol 176, 537–543 (2006). [DOI] [PubMed] [Google Scholar]
  • 77.Zammit DJ, Turner DL, Klonowski KD, Lefrancois L & Cauley LS Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24, 439–449, doi: 10.1016/j.immuni.2006.01.015 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Marconett CN, Zhou B, Rieger ME, Selamat SA, Dubourd M, Fang X, Lynch SK, Stueve TR, Siegmund KD, Berman BP, Borok Z & Laird-Offringa IA Integrated transcriptom ic and epigenomic analysis of prim ary hum an lung epithelial cell differentiation. PLoS Genet 9, e1003513, doi: 10.1371/journal.pgen.1003513 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Hogan BV, Peter MB, Shenoy HG, Horgan K & Hughes TA Surgery induced immunosuppression. Surgeon 9, 38–43, doi: 10.1016/j.surge.2010.07.011 (2011). [DOI] [PubMed] [Google Scholar]
  • 80.Hayashizaki K, Kimura MY, Tokoyoda K, Hosokawa H, Shinoda K, Hirahara K, Ichikawa T, Onodera A, Hanazawa A, Iwamura C, Kakuta J, Muramoto K, Motohashi S, Tumes DJ, Iinuma T, Yamamoto H, Ikehara Y, Okamoto Y & Nakayama T Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation. Sci Immunol 1, eaaf9154, doi: 10.1126/sciimmunol.aaf9154 (2016). [DOI] [PubMed] [Google Scholar]
  • 81.Gilchuk P, Hill TM, Guy C, McMaster SR, Boyd KL, Rabacal WA, Lu P, Shyr Y, Kohlmeier JE, Sebzda E, Green DR & Joyce S A Distinct Lung-Interstitium- Resident Memory CD8(+) T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection. Cell Rep 16, 1800–1809, doi: 10.1016/j.celrep.2016.07.037 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.McMaster SR, Wilson JJ, Wang H & Kohlmeier JE Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-gamma Production. J Immunol 195, 203–209, doi: 10.4049/jimmunol.1402975 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Slutter B, Pewe LL, Kaech SM & Harty JT Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus. Immunity 39, 939–948, doi: 10.1016/j.immuni.2013.09.013 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kadoki M, Patil A, Thaiss CC, Brooks DJ, Pandey S, Deep D, Alvarez D, von Andrian UH, Wagers AJ, Nakai K, Mikkelsen TS, Soumillon M & Chevrier N Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues. Cell 171, 398–413 e321, doi: 10.1016/j.cell.2017.08.024 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Pizzolla A, Wang Z, Groom JR, Kedzierska K, Brooks AG, Reading PC & Wakim LM Nasal-associated lymphoid tissues (NALTs) support the recall but not prim ing of influenza virus-specific cytotoxic T cells. Proc Natl Acad Sci U S A 114, 5225–5230, doi: 10.1073/pnas.1620194114 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Woon HG, Braun A, Li J, Smith C, Edwards J, Sierro F, Feng CG, Khanna R, Elliot M, Bell A, Hislop AD, Tangye SG, Rickinson AB, Gebhardt T, Britton WJ & Palendira U Com partmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs. PLoS Pathog 12, e1005799, doi: 10.1371/journal.ppat.1005799 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Bergsbaken T & Bevan MJ Proinflammatory m icroenvironments within the intestine regulate the differentiation of tissue-resident CD8(+) T cells responding to infection. Nat Immunol 16, 406–414, doi: 10.1038/ni.3108 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, W herry EJ, Hogquist K, Vezys V & Masopust D Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol 188, 4866–4875, doi: 10.4049/jimmunol.1200402 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Bergsbaken T, Bevan MJ & Fink PJ Local Inflammatory Cues Regulate Differentiation and Persistence of CD8(+) Tissue-Resident Memory T Cells. Cell Rep 19, 114–124, doi: 10.1016/j.celrep.2017.03.031 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Zhang N & Bevan MJ Transforming growth factor-beta signaling controls the formation and m aintenance of gut-resident memory T cells by regulating migration and retention. Immunity 39, 687–696, doi: 10.1016/j.immuni.2013.08.019 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Sowell RT, Rogozinska M, Nelson CE, Vezys V & Marzo AL Cutting edge: generation of effector cells that localize to mucosal tissues and foRM resident memory CD8 T cells is controlled by mTOR. J Immunol 193, 2067–2071, doi: 10.4049/jimmunol.1400074 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Viel S, Marcais A, Guimaraes FS, Loftus R, Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier E, Bienvenu J, Marie JC, Caux C, Marvel J, Town L, Huntington ND, Bartholin L, Finlay D, Smyth MJ & Walzer T TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal 9, ra19, doi: 10.1126/scisignal.aad1884 (2016). [DOI] [PubMed] [Google Scholar]
  • 93.Sheridan BS, Pham QM, Lee YT, Cauley LS, Puddington L & Lefrancois L Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. Immunity 40, 747–757, doi: 10.1016/j.immuni.2014.03.007 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V & Masopust D IL-15-Independent M aintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. J Immunol 196, 3920–3926, doi: 10.4049/jimmunol.1502337 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Swamy M, Abeler-Dorner L, Chettle J, Mahlakoiv T, Goubau D, Chakravarty P, Ramsay G, Reis e Sousa C, Staeheli P, Blacklaws BA, Heeney JL & Hayday AC Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance. Nat Commun 6, 7090, doi: 10.1038/ncomms8090 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Khan S, Woodruff EM, Trapecar M, Fontaine KA, Ezaki A, Borbet TC, Ott M & Sanjabi S Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med 213, 2913–2929, doi: 10.1084/jem.20161289 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Iwasaki A Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 10, 699–711, doi: 10.1038/nri2836 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Nakanishi Y, Lu B, Gerard C & Iwasaki A CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462, 510–513, doi: 10.1038/nature08511 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Oh JE, Kim BC, Chang DH, Kwon M, Lee SY, Kang D, Kim JY, Hwang I, Yu JW, Nakae S & Lee HK Dysbiosis-induced IL-33 contributes to im paired antiviral immunity in the genital mucosa. Proc Natl Acad Sci U S A 113, E762–771, doi: 10.1073/pnas.1518589113 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Wang Y, Sui Y, Kato S, Hogg AE, Steel JC, Morris JC & Berzofsky JA Vaginal type-II mucosa is an inductive site for prim ary CD8(+) T-cell mucosal immunity. Nat Commun 6, 6100, doi: 10.1038/ncomms7100 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Shin H & Iwasaki A A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491, 463–467, doi: 10.1038/nature11522 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V & Masopust D T cell memory. Resident mem ory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98–101, doi: 10.1126/science.1254536 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Schenkel JM, Fraser KA, Vezys V & Masopust D Sensing and alaRM function of resident memory CD8(+) T cells. Nat Immunol 14, 509–513, doi: 10.1038/ni.2568 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Shin H, Kumamoto Y, Gopinath S & Iwasaki A CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2. Nat Commun 7, 13346, doi: 10.1038/ncomms13346 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Wakim LM, Waithman J, van Rooijen N, Heath WR & Carbone FR Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319, 198–202, doi: 10.1126/science.1151869 (2008). [DOI] [PubMed] [Google Scholar]
  • 106.Macleod BL, Bedoui S, Hor JL, Mueller SN, Russell TA, Hollett NA, Heath WR, Tscharke DC, Brooks AG & Gebhardt T Distinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1. PLoS Pathog 10, e1004303, doi: 10.1371/journal.ppat.1004303 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Beura LK, Mitchell JS, Thompson EA, Schenkel JM, Mohammed J, Wijeyesinghe S, Fonseca R, Burbach BJ, Hickman HD, Vezys V, Fife BT & Masopust D Intravital mucosal imaging of CD8(+) resident mem ory T cells shows tissue-autonom ous recall responses that amplify secondary memory. Nat Immunol 19, 173–182, doi: 10.1038/s41590-017-0029-3 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igyarto BZ, Southern PJ & Masopust D Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance. Cell 161, 737–749, doi: 10.1016/j.cell.2015.03.031 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Ma C, Mishra S, Demel EL, Liu Y & Zhang N TGF-beta Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation. J Immunol 198, 749–756, doi: 10.4049/jimmunol.1601500 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Frost EL, Kersh AE, Evavold BD & Lukacher AE Cutting Edge: Resident Memory CD8 T Cells Express High-Affinity TCRs. J Immunol 195, 3520–3524, doi: 10.4049/jimmunol.1501521 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Mackay LK, Minnich M, Kragten NA, Liao Y, Nota B, Seillet C, Zaid A, Man K, Preston S, Freestone D, Braun A, Wynne-Jones E, Behr FM, Stark R, Pellicci DG, Godfrey DI, Belz GT, Pellegrini M, Gebhardt T, Busslinger M, Shi W, Carbone FR, van Lier RA, Kallies A & van Gisbergen KP Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459–463, doi: 10.1126/science.aad2035 (2016). [DOI] [PubMed] [Google Scholar]
  • 112.Milner JJ, Toma C, Yu B, Zhang K, Omilusik K, Phan AT, Wang D, Getzler AJ, Nguyen T, Crotty S, Wang W, Pipkin ME & Goldrath AW Runx3 program s CD8(+) T cell residency in non-lymphoid tissues and tum ours. Nature 552, 253–257, doi: 10.1038/nature24993 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.van Aalderen MC, Remmerswaal EB, Heutinck KM, Ten Brinke A, Feltkamp MC, van der Weerd NC, van der Pant KA, Bemelman FJ, van Lier RA & Ten Berge IJ Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells. PLoS Pathog 12, e1005903, doi: 10.1371/journal.ppat.1005903 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Thom JT, Weber TC, Walton SM, Torti N & Oxenius A The Salivary Gland Acts as a Sink for Tissue-Resident Memory CD8(+) T Cells, Facilitating Protection from Local Cytomegalovirus Infection. Cell Rep 13, 1125–1136, doi: 10.1016/j.celrep.2015.09.082 (2015). [DOI] [PubMed] [Google Scholar]
  • 115.Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, Kurup D, Tandon M, Alevizos I & Snyder CM The Chemokine Receptor CXCR3 Promotes CD8(+) T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection. J Immunol 200, 1133–1145, doi: 10.4049/jimmunol.1701272 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Hofmann M & Pircher H E-cadherin prom otes accumulation of a unique memory CD8 T-cell population in murine salivary glands. Proc Natl Acad Sci U S A 108, 16741–16746, doi: 10.1073/pnas.1107200108 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Woyciechowski S, Hofmann M & Pircher H alpha4 beta1 integrin prom otes accumulation of tissue-resident mem ory CD8(+) T cells in salivary glands. Eur J Immunol 47, 244–250, doi: 10.1002/eji.201646722 (2017). [DOI] [PubMed] [Google Scholar]
  • 118.Smith CJ, Caldeira-Dantas S, Turula H & Snyder CM Murine CMV Infection Induces the Continuous Production of Mucosal Resident T Cells. Cell Rep 13, 1137–1148, doi: 10.1016/j.celrep.2015.09.076 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Crispe IN The liver as a lymphoid organ. Annu Rev Immunol 27, 147–163, doi: 10.1146/annurev.immunol.021908.132629 (2009). [DOI] [PubMed] [Google Scholar]
  • 120.Fernandez-Ruiz D, Ng WY, Holz LE, Ma JZ, Zaid A, Wong YC, Lau LS, Mollard V, Cozijnsen A, Collins N, Li J, Davey GM, Kato Y, Devi S, Skandari R, Pauley M, Manton JH, Godfrey DI, Braun A, Tay SS, Tan PS, Bowen DG, Koch-Nolte F, Rissiek B, Carbone FR, Crabb BS, Lahoud M, Cockburn IA, Mueller SN, Bertolino P, McFadden GI, Caminschi I & Heath WR Liver-Resident Memory CD8(+) T Cells FoRM a Front-Line Defense against Malaria Liver-Stage Infection. Immunity 45, 889–902, doi: 10.1016/j.immuni.2016.08.011 (2016). [DOI] [PubMed] [Google Scholar]
  • 121.McNamara HA, Cai Y, Wagle MV, Sontani Y, Roots CM, Miosge LA, O’Connor JH, Sutton HJ, Ganusov VV, Heath WR, Bertolino P, Goodnow CG, Parish IA, Enders A & Cockburn IA Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and rem ain in the hepatic sinusoids. Sci Immunol 2, doi: 10.1126/sciimmunol.aaj1996 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Guidotti LG, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, Fiocchi A, Vacca M, Aiolfi R, Sammicheli S, Mainetti M, Cataudella T, Raimondi A, Gonzalez-Aseguinolaza G, Protzer U, Ruggeri ZM, Chisari FV, Isogawa M, Sitia G & Iannacone M Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161, 486–500, doi: 10.1016/j.cell.2015.03.005 (2015). [DOI] [PubMed] [Google Scholar]
  • 123.Pallett LJ, Davies J, Colbeck EJ, Robertson F, Hansi N, Easom NJW, Burton AR, Stegmann KA, Schurich A, Swadling L, Gill US, Male V, Luong T, Gander A, Davidson BR, Kennedy PTF & Maini MK IL-2(high) tissue-resident T cells in the hum an liver: Sentinels for hepatotropic infection. J Exp Med 214, 1567–1580, doi: 10.1084/jem.20162115 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, Schildberg FA, Odenthal M, Dienes HP, van Rooijen N, Schmitt E, Garbi N, Croft M, Kurts C, Kubes P, Protzer U, Heikenwalder M & Knolle PA Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol 14, 574–583, doi: 10.1038/ni.2573 (2013). [DOI] [PubMed] [Google Scholar]
  • 125.Wakim LM, Woodward-Davis A & Bevan MJ Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc Natl Acad Sci U S A 107, 17872–17879, doi: 10.1073/pnas.1010201107 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Wakim LM, Woodward-Davis A, Liu R, Hu Y, Villadangos J, Smyth G & Bevan MJ The molecular signature of tissue resident mem ory CD8 T cells isolated from the brain. J Immunol 189, 3462–3471, doi: 10.4049/jimmunol.1201305 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Graham JB, Da Costa A & Lund JM Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. J Immunol 192, 683–690, doi: 10.4049/jimmunol.1202153 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Steinbach K, Vincenti I, Kreutzfeldt M, Page N, Muschaweckh A, Wagner I, Drexler I, Pinschewer D, Korn T & Merkler D Brain-resident memory T cells represent an autonom ous cytotoxic barrier to viral infection. J Exp Med 213, 1571–1587, doi: 10.1084/jem.20151916 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Pavelko KD, Bell MP, Harrington SM & Dong H B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous System. Front Immunol 8, 1532, doi: 10.3389/fimmu.2017.01532 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Han SJ, Glatman Zaretsky A, Andrade-Oliveira V, Collins N, Dzutsev A, Shaik J, Morais da Fonseca D, Harrison OJ, Tamoutounour S, Byrd AL, Smelkinson M, Bouladoux N, Bliska JB, Brenchley JM, Brodsky IE & Belkaid Y White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection. Immunity 47, 1154–1168 e1156, doi: 10.1016/j.immuni.2017.11.009 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Natoli G Maintaining cell identity through global control of genomic organization. Immunity 33, 12–24, doi: 10.1016/j.immuni.2010.07.006 (2010). [DOI] [PubMed] [Google Scholar]
  • 132.Mackay LK & Kallies A Transcriptional Regulation of Tissue-Resident Lymphocytes. Trends Immunol 38, 94–103, doi: 10.1016/j.it.2016.11.004 (2017). [DOI] [PubMed] [Google Scholar]
  • 133.Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA & Jameson SC Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442, 299–302, doi: 10.1038/nature04882 (2006). [DOI] [PubMed] [Google Scholar]
  • 134.Takada K, Wang X, Hart GT, Odumade OA, Weinreich MA, Hogquist KA & Jameson SC Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. J Immunol 186, 775–783, doi: 10.4049/jimmunol.1000094 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Iijima N & Iwasaki A T cell memory. A local macrophage chemokine netw ork sustains protective tissue-resident mem ory CD4 T cells. Science 346, 93–98, doi: 10.1126/science.1257530 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Daussy C, Faure F, Mayol K, Viel S, Gasteiger G, Charrier E, Bienvenu J, Henry T, Debien E, Hasan UA, Marvel J, Yoh K, Takahashi S, Prinz I, de Bernard S, Buffat L & Walzer T T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 211, 563–577, doi: 10.1084/jem.20131560 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Odumade OA, Weinreich MA, Jameson SC & Hogquist KA Kruppel-like factor 2 regulates trafficking and homeostasis of gammadelta T cells. J Immunol 184, 6060–6066, doi: 10.4049/jimmunol.1000511 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Kallies A & Good-Jacobson KL Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System. Trends Immunol 38, 287–297, doi: 10.1016/j.it.2017.02.003 (2017). [DOI] [PubMed] [Google Scholar]
  • 139.Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L & Kaech SM Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281–295, doi: 10.1016/j.immuni.2007.07.010 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Klose CS, Blatz K, d’Hargues Y, Hernandez PP, Kofoed-Nielsen M, Ripka JF, Ebert K, Arnold SJ, Diefenbach A, Palmer E & Tanriver Y The transcription factor T-bet is induced by IL-15 and thymic agonist selection and controls CD8alphaalpha(+) intraepithelial lymphocyte development. Immunity 41, 230–243, doi: 10.1016/j.immuni.2014.06.018 (2014). [DOI] [PubMed] [Google Scholar]
  • 141.Reis BS, Hoytema van Konijnenburg DP, Grivennikov SI & Mucida D Transcription factor T-bet regulates intraepithelial lymphocyte functional m aturation. Immunity 41, 244–256, doi: 10.1016/j.immuni.2014.06.017 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Zens KD, Chen JK, Guyer RS, Wu FL, Cvetkovski F, Miron M & Farber DL Reduced generation of lung tissue-resident memory T cells during infancy. J Exp Med 214, 2915–2932, doi: 10.1084/jem.20170521 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Shi Y & Massague J Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685–700 (2003). [DOI] [PubMed] [Google Scholar]
  • 144.Gu AD, Zhang S, Wang Y, Xiong H, Curtis TA & Wan YY A critical role for transcription factor Smad4 in T cell function that is independent of transfoRM ing growth factor beta receptor signaling. Immunity 42, 68–79, doi: 10.1016/j.immuni.2014.12.019 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA & Massague J Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125, 929–941, doi: 10.1016/j.cell.2006.03.045 (2006). [DOI] [PubMed] [Google Scholar]
  • 146.Zhang YE Non-Smad pathways in TGF-beta signaling. Cell Res 19, 128–139, doi: 10.1038/cr.2008.328 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Zhang S, Takaku M, Zou L, Gu AD, Chou WC, Zhang G, Wu B, Kong Q, Thomas SY, Serody JS, Chen X, Xu X, Wade PA, Cook DN, Ting JPY & Wan YY Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551, 105–109, doi: 10.1038/nature24283 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, Muto G, Shichita T, Takahashi R & Yoshimura A Transcription factor Smad-independent T helper 17 cell induction by transfoRM ing-growth factor-beta is mediated by suppression of eomesodermin. Immunity 34, 741–754, doi: 10.1016/j.immuni.2011.02.021 (2011). [DOI] [PubMed] [Google Scholar]
  • 149.Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R, Ichiyama K, Takahashi R, Asakawa M, Muto G, Mori T, Hasegawa E, Saika S, Hara T, Nomura M & Yoshimura A Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J Immunol 185, 842–855, doi: 10.4049/jimmunol.0904100 (2010). [DOI] [PubMed] [Google Scholar]
  • 150.Xin A, Masson F, Liao Y, Preston S, Guan T, Gloury R, Olshansky M, Lin JX, Li P, Speed TP, Smyth GK, Ernst M, Leonard WJ, Pellegrini M, Kaech SM, Nutt SL, Shi W, Belz GT & Kallies A A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nat Immunol 17, 422–432, doi: 10.1038/ni.3410 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Kumar BV, Ma W, Miron M, Granot T, Guyer RS, Carpenter DJ, Senda T, Sun X, Ho SH, Lerner H, Friedman AL, Shen Y & Farber DL Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. Cell Rep 20, 2921–2934, doi: 10.1016/j.celrep.2017.08.078 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Oja AE, Piet B, Helbig C, Stark R, van der Zwan D, Blaauwgeers H, Remmerswaal EBM, Amsen D, Jonkers RE, Moerland PD, Nolte MA, van Lier RAW & Hombrink P Trigger-happy resident memory CD4(+) T cells inhabit the human lungs. Mucosal Immunol, doi: 10.1038/mi.2017.94 (2017). [DOI] [PubMed] [Google Scholar]
  • 153.Vieira Braga FA, Hertoghs KM, Kragten NA, Doody GM, Barnes NA, Remmerswaal EB, Hsiao CC, Moerland PD, W outers D, Derks IA, van Stijn A, Demkes M, Hamann J, Eldering E, Nolte MA, Tooze RM, ten Berge IJ, van Gisbergen KP & van Lier RA Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans. Eur J Immunol 45, 2945–2958, doi: 10.1002/eji.201545650 (2015). [DOI] [PubMed] [Google Scholar]
  • 154.Collins A, Littman DR & Taniuchi I RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat Rev Immunol 9, 106–115, doi: 10.1038/nri2489 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, Wuerch A, Ludwig Y, Fukuyama H, W ardemann H, Waldschuetz R, Moroy T, Taniuchi I, Steimle V, Littman DR & Ehlers M Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells. J Immunol 175, 1694–1705 (2005). [DOI] [PubMed] [Google Scholar]
  • 156.Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T & Taniuchi I Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825, doi: 10.1126/science.1151844 (2008). [DOI] [PubMed] [Google Scholar]
  • 157.Cruz-Guilloty F, Pipkin ME, Djuretic IM, Levanon D, Lotem J, Lichtenheld MG, Groner Y & Rao A Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 206, 51–59, doi: 10.1084/jem.20081242 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Lotem J, Levanon D, Negreanu V, Leshkowitz D, Friedlander G & Groner Y Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLoS One 8, e80467, doi: 10.1371/journal.pone.0080467 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Shan Q, Zeng Z, Xing S, Li F, Hartwig SM, Gullicksrud JA, Kurup SP, Van Braeckel-Budimir N, Su Y, Martin MD, Varga SM, Taniuchi I, Harty JT, Peng W, Badovinac VP & Xue HH The transcription factor Runx3 guards cytotoxic CD8(+) effector T cells against deviation tow ards follicular helper T cell lineage. Nat Immunol 18, 931–939, doi: 10.1038/ni.3773 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, Reis BS, Huang Y, Lambolez F, Docherty M, Attinger A, Shui JW, Kim G, Lena CJ, Sakaguchi S, Miyamoto C, Wang P, Atarashi K, Park Y, Nakayama T, Honda K, Ellmeier W, Kronenberg M, Taniuchi I & Cheroutre H Transcriptional reprogram m ing of m ature CD4(+) helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol 14, 281–289, doi: 10.1038/ni.2523 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I & Mucida D Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4(+) T cell immunity. Nat Immunol 14, 271–280, doi: 10.1038/ni.2518 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Rodriguez-Calvo R, Tajes M & Vazquez-Carrera M The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases. Expert Opin Ther Targets 21, 291–304, doi: 10.1080/14728222.2017.1279146 (2017). [DOI] [PubMed] [Google Scholar]
  • 163.Nowyhed HN, Huynh TR, Blatchley A, Wu R, Thomas GD & Hedrick CC The nuclear receptor nr4a1 controls CD8 T cell development through transcriptional suppression of runx3. Sci Rep 5, 9059, doi: 10.1038/srep09059 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Nowyhed HN, Huynh TR, Thomas GD, Blatchley A & Hedrick CC Cutting Edge: The Orphan Nuclear Receptor Nr4a1 Regulates CD8+ T Cell Expansion and Effector Function through Direct Repression of Irf4. J Immunol 195, 3515–3519, doi: 10.4049/jimmunol.1403027 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Boddupalli CS, Nair S, Gray SM, Nowyhed HN, Verma R, Gibson JA, Abraham C, Narayan D, Vasquez J, Hedrick CC, Flavell RA, Dhodapkar KM, Kaech SM & Dhodapkar MV ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest 126, 3905–3916, doi: 10.1172/JCI85329 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M, Klebanoff CA, Eil RL, Hickman HD, Yu Z, Pan JH, Palmer DC, Phan AT, Goulding J, Gattinoni L, Goldrath AW, Belkaid Y & Restifo NP Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell 166, 1117–1131 e1114, doi: 10.1016/j.cell.2016.07.032 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Zaid A, Mackay LK, Rahimpour A, Braun A, Veldhoen M, Carbone FR, Manton JH, Heath WR & Mueller SN Persistence of skin-resident memory T cells within an epideRM al niche. Proc Natl Acad Sci U S A 111, 5307–5312, doi: 10.1073/pnas.1322292111 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Kadow S, Jux B, Zahner SP, W ingerath B, Chmill S, Clausen BE, Hengstler J & Esser C Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the m urine epidermis. J Immunol 187, 3104–3110, doi: 10.4049/jimmunol.1100912 (2011). [DOI] [PubMed] [Google Scholar]
  • 169.Li Y, Innocentin S, W ithers DR, Roberts NA, Gallagher AR, Grigorieva EF, Wilhelm C & Veldhoen M Exogenous stimuli m aintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629–640, doi: 10.1016/j.cell.2011.09.025 (2011). [DOI] [PubMed] [Google Scholar]
  • 170.Turner DL & Farber DL Mucosal resident memory CD4 T cells in protection and immunopathology. Front Immunol 5, 331, doi: 10.3389/fimmu.2014.00331 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Burzyn D, Benoist C & Mathis D Regulatory T cells in nonlymphoid tissues. Nat Immunol 14, 1007–1013, doi: 10.1038/ni.2683 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Gratz IK & Campbell DJ Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol 5, 333, doi: 10.3389/fimmu.2014.00333 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Collins N, Jiang X, Zaid A, Macleod BL, Li J, Park CO, Haque A, Bedoui S, Heath WR, Mueller SN, Kupper TS, Gebhardt T & Carbone FR Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nat Commun 7, 11514, doi: 10.1038/ncom m s11514 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Park CO, Fu X, Jiang X, Pan Y, Teague JE, Collins N, Tian T, O’Malley JT, Emerson RO, Kim JH, Jung Y, W atanabe R, Fuhlbrigge RC, Carbone FR, Gebhardt T, Clark RA, Lin CP & Kupper TS Staged development of long-lived T-cell receptor alphabeta TH17 resident memory T-cell population to Candida albicans after skin infection. J Allergy Clin Immunol, doi: 10.1016/j.jaci.2017.09.042 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Glennie ND, Yeramilli VA, Beiting DP, Volk SW, Weaver CT & Scott P Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection. J Exp Med 212, 1405–1414, doi: 10.1084/jem.20142101 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Glennie ND, Volk SW & Scott P Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes. PLoS Pathog 13, e1006349, doi: 10.1371/journal.ppat.1006349 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Thome JJ, Bickham KL, Ohmura Y, Kubota M, Matsuoka N, Gordon C, Granot T, Griesemer A, Lerner H, Kato T & Farber DL Early-life com partmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues. Nat Med 22, 72–77, doi: 10.1038/nm.4008 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L & Farber DL Cutting edge: Tissue-retentive lung mem ory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187, 5510–5514, doi: 10.4049/jimmunol.1102243 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179.Strutt TM, Dhume K, Finn CM, Hwang JH, Castonguay C, Swain SL & McKinstry KK IL-15 supports the generation of protective lung-resident memory CD4 T cells. Mucosal Immunol, doi: 10.1038/mi.2017.101 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180.Hondowicz BD, An D, Schenkel JM, Kim KS, Steach HR, Krishnamurty AT, Keitany GJ, Garza EN, Fraser KA, Moon JJ, Altemeier WA, Masopust D & Pepper M Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma. Immunity 44, 155–166, doi: 10.1016/j.immuni.2015.11.004 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181.Hondowicz BD, Kim KS, Ruterbusch MJ, Keitany GJ & Pepper M IL-2 is required for the generation of viral-specific CD4(+) Th1 tissue-resident memory cells and B cells are essential for m aintenance in the lung. Eur J Immunol 48, 80–86, doi: 10.1002/eji.201746928 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182.Turner DL, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, Cao M, Dave R, Tanna N, D’Armiento JM & Farber DL Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol 200, 1561–1569, doi: 10.4049/jimmunol.1700257 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Thawer SG, Horsnell WG, Darby M, Hoving JC, Dewals B, Cutler AJ, Lang D & Brombacher F Lung-resident CD4(+) T cells are sufficient for IL-4Ralpha-dependent recall immunity to Nippostrongylus brasiliensis infection. Mucosal Immunol 7, 239–248, doi: 10.1038/mi.2013.40 (2014). [DOI] [PubMed] [Google Scholar]
  • 184.Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN & von Andrian UH VACCINES. A mucosal vaccine against Chlamydia trachom atis generates two waves of protective memory T cells. Science 348, aaa8205, doi: 10.1126/science.aaa8205 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, Cella M, Gordon JI, Hsieh CS & Colonna M Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science 357, 806–810, doi: 10.1126/science.aah5825 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Sujino T, London M, Hoytema van Konijnenburg DP, Rendon T, Buch T, Silva HM, Lafaille JJ, Reis BS & Mucida D Tissue adaptation of regulatory and intraepithelial CD4(+) T cells controls gut inflammation. Science 352, 1581–1586, doi: 10.1126/science.aaf3892 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Romagnoli PA, Fu HH, Qiu Z, Khairallah C, Pham QM, Puddington L, Khanna KM, Lefrancois L & Sheridan BS Differentiation of distinct long-lived memory CD4 T cells in intestinal tissues after oral Listeria monocytogenes infection. Mucosal Immunol 10, 520–530, doi: 10.1038/mi.2016.66 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Steinfelder S, Rausch S, Michael D, Kuhl AA & Hartmann S Intestinal helminth infection induces highly functional resident memory CD4(+) T cells in mice. Eur J Immunol 47, 353–363, doi: 10.1002/eji.201646575 (2017). [DOI] [PubMed] [Google Scholar]
  • 189.Tomura M, Itoh K & Kanagawa O Naive CD4+ T lymphocytes circulate through lymphoid organs to interact with endogenous antigens and upregulate their function. J Immunol 184, 4646–4653, doi: 10.4049/jimmunol.0903946 (2010). [DOI] [PubMed] [Google Scholar]
  • 190.Ugur M, Schulz O, Menon MB, Krueger A & Pabst O Resident CD4+ T cells accumulate in lymphoid organs after prolonged antigen exposure. Nat Commun 5, 4821, doi: 10.1038/ncom m s5821 (2014). [DOI] [PubMed] [Google Scholar]
  • 191.Marriott CL, Dutton EE, Tomura M & Withers DR Retention of Ag-specific memory CD4(+) T cells in the draining lymph node indicates lymphoid tissue resident memory populations. Eur J Immunol 47, 860–871, doi: 10.1002/eji.201646681 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES